Diverter sensor implant anchoring

By implanting a sensor device in the heart to directly monitor left atrial pressure, the problem of inaccurate monitoring in existing technologies has been solved, enabling early prediction and treatment of heart failure and reducing hospitalization rates and the occurrence of complications.

CN115363822BActive Publication Date: 2026-11-10EDWARDS LIFESCIENCES CORP
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202210548756.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2021-08-19
Filing Date
2022-05-20
Publication Date
2026-11-10
Estimated Expiration
2042-05-20

AI Technical Summary

Technical Problem

Existing technologies are insufficient to effectively monitor left atrial pressure within the heart, making early diagnosis and treatment of congestive heart failure difficult. Traditional methods, such as E/A ratio and pulmonary artery pressure measurement, are either inaccurate or highly invasive.

Method used

An implantable device with integrated sensors is delivered into the heart via a catheter or guidewire to directly monitor left atrial pressure. Combined with pressure sensors and control circuitry, it enables wireless signal transmission and data processing, providing accurate cardiac pressure monitoring.

Benefits of technology

It enables precise monitoring of left atrial pressure, early prediction of heart failure, guidance of drug therapy, reduction of hospitalization and complications, and improvement of the effectiveness of preventive health care for patients.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115363822B_ABST
    Figure CN115363822B_ABST
Patent Text Reader

Abstract

This application is titled "Shunt Sensor Implant Anchoring". A sensor implantation system includes a shunt implant comprising a central flow portion configured to maintain an opening through a tissue wall, and a sensor implantation device. The sensor implantation device includes a shunt body configured to be at least partially fitted within the central flow portion of the shunt implant and a sensor device coupled to the shunt body.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] Related applications

[0002] This application claims based on U.S. Provisional Patent Application Serial No. 63 / 191,534, filed May 21, 2021, entitled “IMPLANT-COUPLED SENSORS”; U.S. Provisional Patent Application Serial No. 63 / 224,286, filed July 21, 2021, entitled “IMPLANT-ADJACENT SENSOR ANCHORING”; U.S. Provisional Patent Application Serial No. 63 / 225,039, filed July 23, 2021, entitled “SHUNT BARREL SENSOR IMPLANT ANCHORING”; U.S. Provisional Patent Application Serial No. 63 / 225,689, filed July 26, 2021, entitled “EMBEDDED SENSOR IMPLANT DEVICES”; and U.S. Provisional Patent Application Serial No. 63 / 225,689, filed August 19, 2021, entitled “SENSOR”. Priority is given to U.S. Provisional Patent Application Serial No. 63 / 235,038, entitled “IMPLANT DEVICEANCHORING”, the entire disclosure of which is incorporated herein by reference. Technical Field

[0003] This disclosure generally pertains to the field of medical implantable devices. Background Technology

[0004] Various medical procedures involve implanting medical devices within the anatomical structures of the heart. Certain physiological parameters associated with this anatomy, such as fluid pressure, can influence a patient's health prospects. Summary of the Invention

[0005] This article describes one or more methods and / or devices to facilitate the use of one or more sensor implantation devices to monitor one or more physiological parameters associated with certain chambers and / or vessels of the heart, such as the left atrium.

[0006] For the purpose of summarizing this disclosure, certain aspects, advantages, and novel features have been described. It should be understood that not all of these advantages can necessarily be achieved according to any particular example. Therefore, the disclosed examples may be implemented in a manner that achieves or optimizes one or a set of advantages as taught herein without necessarily achieving other advantages as taught or suggested herein. Attached Figure Description

[0007] For illustrative purposes, various examples are depicted in the accompanying drawings and should in no way be construed as limiting the scope of the invention. Furthermore, various features of different disclosed examples can be combined to form additional examples, which are part of this disclosure. Throughout the drawings, reference numerals may be repeated to indicate correspondences between reference elements.

[0008] Figure 1 The illustration shows an example representation of the human heart based on one or more examples.

[0009] Figure 2 The illustration shows example pressure waveforms associated with various chambers and blood vessels of the heart, based on one or more examples.

[0010] Figure 3 The diagram shows a graph displaying the range of pressure in the left atrium.

[0011] Figure 4 It is a block diagram representing an implantable device based on one or more examples.

[0012] Figure 5 It is a block diagram representing a system for monitoring one or more physiological parameters associated with a patient, based on one or more examples.

[0013] Figure 6 The illustration shows an example sensor component / device according to one or more examples, which may be a component of a sensor implantation device.

[0014] Figure 7 The illustration shows an example shunt / anchor structure that can be configured to be attached to one or more sensor devices, according to one or more examples.

[0015] Figure 8 The diagram illustrates a shunt implant / anchoring device / structure implanted in an atrial septum according to one or more examples.

[0016] Figure 9 A shunt device / structure implanted in the tissue wall between the coronary sinus and the left atrium is shown.

[0017] Figure 10A and 10B An example sensor implantation device according to one or more examples of this disclosure is illustrated.

[0018] Figure 11A and 11B An example sensor implantation device according to one or more examples of this disclosure is illustrated.

[0019] Figure 12A and 12BThe illustration shows a sensor implantation device according to one or more examples, the sensor implantation device including a sensor coupled to a shunt body comprising one or more wire loops and / or extending therefrom.

[0020] Figures 13A-13D The illustration shows another sensor implantation device according to one or more examples, which includes a sensor coupled to a coil shunt body configured to hold the sensor in place at a desired location within the heart.

[0021] Figure 14 A side view of an example sensor implantation device according to one or more examples is provided, the example sensor implantation device including a sensor base configured to be coupled to and / or otherwise cooperate with one or more sensors.

[0022] Figure 15 A side view of an example sensor implantation device according to one or more examples is provided, the example sensor implantation device including a sensor base configured to be coupled to and / or otherwise cooperate with one or more sensors.

[0023] Figure 16 A top view of an example sensor implantation device according to one or more examples is provided, the example sensor implantation device including a sensor base configured to be coupled to and / or otherwise cooperate with one or more sensors.

[0024] Figure 17 The illustration shows an example sensor implantation device with a shunt implant according to one or more examples.

[0025] Figure 18A and 18B The illustration shows a sensor implantation device according to one or more examples, which includes a sensor connected to one or more self-deploying anchor arms via one or more tethers.

[0026] Figure 19A and 19B The illustration shows a sensor implantation device according to one or more examples, the sensor implantation device including a sensor connected to a first implant via one or more tethers.

[0027] Figure 20A and 20B The illustration shows a sensor implantation device according to one or more examples, the sensor implantation device including a sensor connected to a first implant via one or more connecting arms.

[0028] Figures 21A-21C The illustration shows another sensor implantation device according to one or more examples, the other sensor implantation device including a sensor coupled to a cylindrical portion of the sensor implantation device.

[0029] Figure 22 A flowchart illustrating the steps of a process for delivering one or more sensor implantation devices and / or shunt devices as described herein, according to one or more examples, is provided. Detailed Implementation

[0030] The headings provided herein are for convenience only and do not necessarily affect the scope or meaning of the claimed invention.

[0031] Although certain preferred examples and illustrations are disclosed below, the subject matter of the invention extends beyond the specifically disclosed examples to other alternative examples and / or uses, as well as modifications and equivalents thereof. Therefore, the scope of the claims that may arise therefrom is not limited to any particular example described below. For example, in any method or process disclosed herein, the actions or operations of the method or process may be performed in any suitable order and are not necessarily limited to any particular disclosed order. Various operations may be described sequentially as a plurality of discrete operations in a manner that aids in understanding certain examples; however, the order described should not be construed as implying that these operations are order-dependent. Furthermore, the structures, systems, and / or apparatuses described herein may be implemented as integrated components or separate components. For the purpose of comparing various examples, certain aspects and advantages of these examples are described. Not all of these aspects or advantages are necessarily achieved by any particular example. Thus, for example, various examples may be performed in a manner that achieves or optimizes one or a set of advantages as taught herein, without necessarily achieving other aspects or advantages as may also be taught or suggested herein.

[0032] For the convenience of reference to objects, components, systems, features, and / or modules that have similar features in one or more aspects, certain reference numerals are repeated in different figures of this disclosure. However, the repeated use of common reference numerals in the figures with respect to any example disclosed herein does not necessarily indicate that these features, objects, components, or modules are identical or similar. Rather, those skilled in the art can understand from the context that the use of common reference numerals may imply the degree of similarity between the referenced subjects. The use of a particular reference numeral in the context of the description of a particular figure is to be understood as relating to the object, component, aspect, feature, module, or system identified in that particular figure, and not necessarily to any object, component, aspect, feature, module, or system identified with the same reference numerals in another figure. Furthermore, aspects of individual figures identified with common reference numerals may be interpreted as sharing features or being completely independent of each other.

[0033] For preferred examples, certain standard anatomical terms are used herein to refer to the anatomy of animals, i.e., human anatomy. While certain spatially relative terms, such as “external,” “internal,” “upper,” “lower,” “below,” “above,” “vertical,” “horizontal,” “top,” “bottom,” and similar terms, are used herein to describe the spatial relationship of one device / element or anatomical structure to another device / element or anatomical structure, it should be understood that these terms are used herein for the convenience of describing the positional relationship between one or more elements / structures, as illustrated in the figures. It should be understood that, in addition to the orientations depicted in the figures, spatially relative terms are intended to cover different orientations of one or more elements / structures in use or operation. For example, an element / structure described as “above” another element / structure may indicate a position below or adjacent to such other elements / structures relative to the subject / patient or the alternating orientation of the element / structure, and vice versa.

[0034] This disclosure relates to systems, apparatus, and methods for monitoring one or more physiological parameters (e.g., blood pressure) of a patient using a sensor-integrated cardiac shunt and / or other medical implantable device. In some embodiments, this disclosure relates to a cardiac shunt and / or other cardiac implantable device incorporating or associated with a pressure sensor or other sensor device. The term “associated with” is used herein in its broad and general sense. For example, where a first feature, element, component, device, or member is described as being “associated” with a second feature, element, component, device, or member, such a description should be understood to indicate that the first feature, element, component, device, or member is physically coupled, attached, connected to, integrated into, at least partially embedded within, or otherwise physically associated with, whether directly or indirectly, the second feature, element, component, device, or member. Certain examples are disclosed herein in the context of cardiac implantable devices. However, although some of the principles disclosed herein are particularly applicable to the anatomy of the heart, it should be understood that the sensor implantation device according to this disclosure can be implanted or constructed for implantation into any suitable or desired anatomical structure.

[0035] While the various sensor devices described herein can be integrated with the various medical implantable devices described herein, the sensor devices can also be separate from the medical implantable devices. For example, the sensor device can form a disconnectable and / or releasable connection with the medical implantable device. Furthermore, the sensor devices described herein can be configured to deliver the medical implantable device separately (e.g., before and / or after) within the patient's heart. For example, the sensor device may not be attached to the medical implantable device during the delivery process of the sensor device and / or the medical implantable device (e.g., during catheter delivery), but may be attached / coupled to the medical implantable device after delivery to the desired location within the heart (e.g., after removal from the catheter). Example delivery locations may include the left atrium, left atrial appendage, pulmonary veins, coronary sinus, and / or various tissue walls associated with these locations.

[0036] In some examples, catheters and / or guidewires used for delivering sensor devices can also be used for delivering medical implantable devices. For instance, catheters and / or guidewires can remain in the body after delivery of the sensor device and / or medical implantable device to deliver one or more remaining devices.

[0037] Some of the sensor devices described herein can be configured to be delivered prior to the delivery of the medical implantable device described herein. This can advantageously simplify the delivery of the sensor device and / or the medical implantable device and / or provide simple imaging of the sensor device and / or the medical implantable device. The sensor device can be adjusted as needed to maximize the measurements of the sensor device prior to the delivery of the medical implantable device. Furthermore, the delivery of the medical implantable device can be delayed and / or suspended as needed after the delivery of the sensor device.

[0038] Some of the sensor devices described herein can be configured to be delivered after the delivery of the medical implantable device described herein. This can advantageously simplify the delivery of the sensor device and / or the medical implantable device and / or provide simple imaging of the sensor device and / or the medical implantable device. The sensor device can be adjusted as needed to maximize the measurement values ​​of the sensor device. Furthermore, the sensor device can be effectively secured to the medical implantable device with minimal risk of displacement of the sensor device.

[0039] Cardiac Physiology

[0040] The anatomy of the heart is described below to aid in understanding some of the inventive concepts disclosed herein. In humans and other vertebrates, the heart typically comprises a muscular organ with four pump chambers, wherein its flow is controlled at least in part by various cardiac valves, namely the aortic valve, mitral valve (or mitral valve), tricuspid valve, and pulmonary valve. Valves can be configured to open and close in response to pressure gradients present during various phases of the cardiac cycle (e.g., diastole and systole) to at least partially control the flow of blood to corresponding areas of the heart and / or to blood vessels (e.g., the lungs, aorta, etc.).

[0041] Figure 1 The illustration shows an example representation of a heart 1 having various features relevant to certain examples of the disclosure of this invention. The heart 1 includes four chambers: a left atrium 2, a left ventricle 3, a right ventricle 4, and a right atrium 5. In terms of blood flow, blood normally flows from the right ventricle 4 into the pulmonary artery 11 via a pulmonary valve 9, which separates the right ventricle 4 from the pulmonary artery 11 and is configured to open during cardiac systole to pump blood to the lungs and close during cardiac diastole to prevent blood from leaking back into the heart from the pulmonary artery 11. The pulmonary artery 11 delivers deoxygenated blood from the right side of the heart to the lungs. As shown, the pulmonary artery 11 includes the pulmonary trunk and branching from it: a left pulmonary artery 15 and a right pulmonary artery 13. A pulmonary vein 23 carries blood from the lungs to the left atrium 2.

[0042] In addition to the pulmonary valve 9, the heart 1 includes three additional valves to aid blood circulation: the tricuspid valve 8, the aortic valve 7, and the mitral valve 6. The tricuspid valve 8 separates the right atrium 5 from the right ventricle 4. The tricuspid valve 8 typically has three cusps or leaflets and is normally closed during ventricular systole (i.e., cardiac contraction) and open during ventricular expansion (i.e., cardiac diastole). The mitral valve 6 typically has two cusps / leaflets and separates the left atrium 2 from the left ventricle 3. The mitral valve 6 is configured to open during diastole so that blood in the left atrium 2 can flow into the left ventricle 3, and when functioning normally, closes during systole to prevent blood from leaking back into the left atrium 2. The aortic valve 7 separates the left ventricle 3 from the aorta 12. The aortic valve 7 is configured to open during systole to allow blood to leave the left ventricle 3 and enter the aorta 12, and close during diastole to prevent blood from leaking back into the left ventricle 3.

[0043] Heart valves typically comprise a relatively dense fibrous ring, referred to herein as the valve annulus, and multiple leaflets or cusps attached to the annulus. Typically, the leaflets or cusps are sized such that, when the heart contracts, the resulting increase in blood pressure within the corresponding heart chamber forces the leaflets to open at least partially to allow flow out of the heart chamber. As the pressure within the heart chamber decreases, the pressure within the subsequent heart chamber or blood vessel may become dominant and press backward against the leaflets. As a result, the leaflets / cusps become juxtaposed against each other, thereby closing the flow pathway. Dysfunction of the heart valve and / or related leaflets (e.g., pulmonary valve dysfunction) can lead to valvular leakage and / or other health complications.

[0044] Atrioventricular (e.g., mitral and tricuspid) heart valves may further include an assembly of chordae tendineae and papillary muscles (not shown) for securing the leaflets of the respective valves to facilitate and / or promote proper engagement of the valve leaflets and prevent their prolapse. For example, papillary muscles may typically include finger-like projections from the ventricular wall. The leaflets are connected to the papillary muscles by chordae tendineae. A muscular wall called a diaphragm separates the left and right chambers of the heart. Specifically, portion 18 of the atrial septum wall (referred to herein as “atrial septum,” “atrial septal membrane,” or “diaphragm”) separates the left atrium 2 from the right atrium 5, while portion 17 of the ventricular septum wall (referred herein as “ventricular septum,” “ventricular septal membrane,” or “diaphragm”) separates the left ventricle 3 from the right ventricle 4. The inferior apex 26 of the heart 1 is called the apex and is typically located on or near the midclavicular line in the fifth intercostal space.

[0045] The coronary sinus 16 comprises a collection of veins that connect to form a large vessel that collects blood from the myocardium (heart muscle). As shown in the figure, the coronary sinus ostium may be at least partially protected by the coronary sinus valve in some patients, opening into the right atrium 5. The coronary sinus extends along the posterior portion of the left atrium 2 and delivers less oxygenated blood to the right atrium 5. The coronary sinus normally runs transversely within the left atrioventricular groove posterior to the heart.

[0046] Any of several access pathways within the heart 1 can be used to manipulate guidewires and catheters within and around the heart 1 to deploy the implant and / or device of this application. For example, access can be made superiorly via the subclavian or jugular vein into the superior vena cava (SVC) 19, the right atrium 5, and from there into the coronary sinus 16. Alternatively, the access pathway can begin from the femoral vein and proceed through the inferior vena cava (IVC) 14 into the heart 1. Other pathways may also be used, and each pathway can utilize a percutaneous incision through which guidewires and catheters are inserted into the vascular system, typically via a sealed guide, from which the physician can remotely control the device from the external end.

[0047] Health conditions related to cardiac stress and other parameters

[0048] As mentioned above, certain physiological conditions or parameters related to cardiac anatomy can affect a patient's health. For example, congestive heart failure is a condition associated with the relatively slow movement of blood through the heart and / or body, leading to increased fluid pressure in one or more chambers of the heart. As a result, the heart cannot pump enough oxygen to meet the body's needs. The individual chambers of the heart can respond to the increased pressure by stretching to retain more blood to pump through the body or by becoming relatively stiff and / or thickened. The heart walls eventually weaken and become unable to pump blood effectively. In some cases, the kidneys may respond to the heart's inefficiency by keeping the body fluid. The accumulation of fluid in the arms, legs, ankles, feet, lungs, and / or other organs causes congestion in the body, a condition known as congestive heart failure. Acute decompensated congestive heart failure is a leading cause of morbidity and mortality, therefore, the treatment and / or prevention of congestive heart failure is an important issue in healthcare.

[0049] Treatment and / or prevention of heart failure (e.g., congestive heart failure) may advantageously involve monitoring pressure in one or more chambers or regions of the heart or other anatomical structures. As mentioned above, pressure buildup in one or more chambers or regions of the heart may be associated with congestive heart failure. Without direct or indirect monitoring of cardiac pressure, it may be difficult to infer, determine, or predict the presence or occurrence of congestive heart failure. For example, treatments or methods that do not involve direct or indirect pressure monitoring may involve measuring or observing other current physiological conditions of the patient, such as measuring weight, chest impedance, right heart catheterization, etc. In some solutions, pulmonary capillary wedge pressure can be measured as a surrogate indicator of left atrial pressure. For example, a pressure sensor can be placed or implanted in the pulmonary artery, and the associated reading can be used as a surrogate value for left atrial pressure. However, catheter-based pressure measurements of the pulmonary artery or certain other chambers or regions of the heart may require the use of invasive catheters to maintain such pressure sensors, which may be uncomfortable or difficult to perform. Furthermore, certain lung-related conditions may affect pressure readings in the pulmonary artery, causing the correlation between pulmonary artery pressure and left atrial pressure to be undesirably weakened. As an alternative to pulmonary artery pressure measurement, pressure measurement in the right ventricular outflow tract may also correlate with left atrial pressure. However, the correlation between this pressure reading and left atrial pressure may not be strong enough to be used for the diagnosis, prevention, and / or treatment of congestive heart failure.

[0050] Additional solutions can be implemented to obtain or infer left atrial pressure. For example, the E / A ratio, an indicator of left ventricular function, representing the ratio of the peak gravitational flow velocity (E wave) in early diastole to the peak flow velocity (A wave) caused by atrial contraction in late diastole, can be used as a proxy for measuring left atrial pressure. The E / A ratio can be determined using echocardiography or other imaging techniques; generally, an abnormal E / A ratio may indicate that the left ventricle is not filling properly with blood between systoles, which, as mentioned above, can lead to symptoms of heart failure. However, E / A ratio determination typically does not provide an absolute pressure measurement.

[0051] Various methods for identifying and / or treating congestive heart failure involve observing worsening symptoms and / or weight changes. However, these signs may appear relatively late and / or be relatively unreliable. For example, daily weight measurements can vary considerably (e.g., by up to 9% or more) and may be unreliable as a signal of cardiac-related complications. Furthermore, treatment guided by monitoring signs, symptoms, weight, and / or other biomarkers has not shown significant improvements in clinical outcomes. Additionally, for discharged patients, such treatment may require telemedicine systems.

[0052] This disclosure provides systems, devices, and methods for guiding drug administration in relation to the treatment of congestive heart failure, at least in part, by direct monitoring of pressure in the left atrium or other heart chambers or blood vessels, to reduce hospital readmissions, morbidity, and / or otherwise improve the health prospects of patients, wherein pressure measurements indicate, for example, left atrial pressure and / or pressure levels in one or more other blood vessels / heart chambers for patients with congestive heart failure.

[0053] Cardiac stress monitoring

[0054] Cardiac pressure monitoring according to examples of this disclosure can provide an active intervention mechanism for the prevention or treatment of congestive heart failure and / or other physiological conditions. Generally, an increase in ventricular filling pressure associated with diastolic and / or systolic heart failure can occur before the onset of symptoms leading to hospitalization. For example, in some patients, cardiac pressure indicators may appear several weeks prior to hospitalization. Therefore, a pressure monitoring system according to examples of this disclosure can be advantageously implemented to reduce hospitalizations by guiding appropriate or desired titrations and / or medications prior to the onset of heart failure.

[0055] Dyspnea represents a cardiac stress indicator, characterized by shortness of breath or a feeling of not being able to breathe properly. Dyspnea may be caused by elevated atrial pressure, which can lead to fluid buildup in the lungs due to pressure rebound. Pathological dyspnea can be caused by congestive heart failure. However, a considerable time may pass between the initial pressure rise and the onset of dyspnea, so the symptoms of dyspnea may not provide a sufficiently early signal of elevated atrial pressure. By directly monitoring pressure according to the examples of this disclosure, normal ventricular filling pressure can be advantageously maintained, thereby preventing or reducing the effects of heart failure such as dyspnea.

[0056] As mentioned above, regarding cardiac pressure, elevated pressure in the left atrium may be particularly associated with heart failure. Figure 2 The illustration shows example pressure waveforms associated with various chambers and blood vessels of the heart, based on one or more examples. Figure 2 The various waveforms shown can represent waveforms obtained using right heart catheterization to advance one or more pressure sensors into the corresponding shown and labeled chambers or vessels of the heart. For example... Figure 2 As shown, waveform 25, representing left atrial pressure, can be considered to provide the best feedback for the early detection of congestive heart failure. Furthermore, there is often a relatively strong correlation between increased left atrial pressure and pulmonary congestion.

[0057] Left atrial pressure is typically closely correlated with left ventricular end-diastolic pressure. However, while there is a clear correlation between left atrial pressure and pulmonary artery end-diastolic pressure, this correlation may weaken when pulmonary vascular resistance is elevated. That is, in the presence of various acute conditions (potentially including some patients with congestive heart failure), pulmonary artery pressure often does not adequately correlate with left ventricular end-diastolic pressure. For example, pulmonary hypertension, affecting approximately 25% to 83% of heart failure patients, can affect the reliability of pulmonary artery pressure measurements used to estimate left filling pressure. Therefore, as illustrated in waveform 24, pulmonary artery pressure measurements alone may be an inadequate or inaccurate indicator of left ventricular end-diastolic pressure, particularly in patients with comorbidities such as lung disease and / or thromboembolism. Left atrial pressure can further be correlated, at least in part, with the presence and / or degree of mitral regurgitation.

[0058] and Figure 2 Compared to other pressure waveforms shown, left atrial pressure readings are relatively less likely to be distorted or affected by other conditions, such as respiratory status. Generally, left atrial pressure can significantly predict heart failure, such as up to two weeks before heart failure manifestations. For example, an increase in left atrial pressure, along with diastolic and systolic heart failure, may occur several weeks before hospitalization, so knowledge of this increase can be used to predict the onset of congestive heart failure, such as acute weakness symptoms of congestive heart failure.

[0059] Cardiac pressure monitoring, such as left atrial pressure monitoring, can provide a mechanism to guide medication administration for the treatment and / or prevention of congestive heart failure. Such treatment can advantageously reduce hospital readmission rates and morbidity, and provide other benefits. Implantable pressure sensors according to examples of this disclosure can be used to predict heart failure two weeks or longer before the onset of symptoms or signs of heart failure (e.g., dyspnea). When cardiac pressure sensor examples are used to identify predictors of heart failure according to this disclosure, certain preventative measures, including pharmacological interventions such as modifying a patient's medication regimen, can be implemented, which can help prevent or reduce the effects of cardiac dysfunction. Direct pressure measurement in the left atrium can advantageously provide an accurate indication of pressure buildup that may lead to heart failure or other complications. For example, trends in elevated atrial pressure can be analyzed or used to identify or predict the onset of cardiac dysfunction, where medications or other therapies can be increased to induce a decrease in pressure and prevent or reduce further complications.

[0060] Figure 3 A graph 300 illustrating the range of left atrial pressure is shown, including a normal range 301 for left atrial pressure that is generally not associated with a substantial risk of postoperative atrial fibrillation, acute kidney injury, myocardial injury, heart failure, and / or other health conditions. Examples of this disclosure provide systems, apparatus, and methods for determining whether a patient's left atrial pressure is within the normal range 301, above the normal range 303, or below the normal range 302 by using certain sensor implantation devices. For a detected left atrial pressure above the normal range, which may be associated with an increased risk of heart failure, examples of this disclosure, as described in detail below, can inform efforts to reduce the left atrial pressure until it falls within the normal range 301. Furthermore, for a detected left atrial pressure below the normal range 301, which may be associated with an increased risk of acute kidney injury, myocardial injury, and / or other health complications, examples of this disclosure, as described in detail below, can be used to encourage efforts to increase the left atrial pressure to bring the pressure level within the normal range 301.

[0061] Implantable devices with integrated sensors

[0062] In some embodiments, this disclosure relates to sensors associated with or integrated with cardiac shunts or other implantable devices. Such integrated devices can be used to provide controlled and / or more effective therapies for the treatment and prevention of heart failure and / or other health complications related to cardiac function. Figure 4This is a block diagram illustrating an implantation device 30 including a shunt (or other type of implant) structure 39. In some examples, the shunt structure 39 is physically integrated with and / or connected to a sensor device 37. The sensor device 37 may be, for example, a pressure sensor or other type of sensor. In some examples, the sensor 37 includes a transducer 32, such as a pressure transducer, and some control circuitry 34 that may be implemented, for example, in an application-specific integrated circuit (ASIC).

[0063] Control circuitry 34 may be configured to process signals received from transducer 32 and / or wirelessly transmit associated signals via antenna 38 through biological tissue. The term "control circuitry" is used herein in its broad and general sense and may refer to any collection of processors, processing circuits, processing modules / units, chips, dies (e.g., semiconductor dies including active or more active and / or passive devices and / or connection circuitry), microprocessors, microcontrollers, digital signal processors, microcomputers, central processing units, field-programmable gate arrays, programmable logic devices, state machines (e.g., hardware state machines), logic circuits, analog circuits, digital circuits, and / or any device that manipulates signals (analog and / or digital) based on circuit-based hard-coded and / or operational instructions. Control circuitry as referred to herein may further include one or more storage devices, which may be implemented in embedded circuitry within a single memory device, multiple memory devices, and / or devices. Such data storage may include read-only memory, random access memory, volatile memory, non-volatile memory, static memory, dynamic memory, flash memory, cache memory, data storage registers, and / or any device storing digital information. It should be noted that in examples where the control circuitry includes hardware and / or software state machines, analog circuitry, digital circuitry, and / or logic circuitry, one or more data storage devices / one or more registers storing any associated operating instructions may be embedded inside or outside the circuitry including the state machine, analog circuitry, digital circuitry, and / or logic circuitry. One or more transducers 32 and / or one or more antennas 38 may be considered part of the control circuitry 34.

[0064] Antenna 38 may include one or more coils or loops of conductive material, such as copper wire. In some examples, at least a portion of transducer 32, control circuitry 34, and / or antenna 38 is at least partially disposed within or contained in sensor housing 36, which may comprise any type of material and may advantageously be at least partially sealed. For example, in some examples, housing 36 may comprise glass or other rigid materials, which may provide mechanical stability and / or protection for components housed therein. In some examples, housing 36 is at least partially flexible. For example, housing may comprise polymers or other flexible structures / materials, which may advantageously allow folding, bending, or collapse of sensor 37 to allow its delivery via conduit or other introduction device.

[0065] Transducer 32 may include any type of sensor device or mechanism. For example, transducer 32 may be a force-harvesting type pressure sensor. In some examples, transducer 32 includes a diaphragm, piston, Bourdon tube, bellows, or one or more other strain or deflection measuring components to measure strain or deflection applied to its area / surface. Transducer 32 may be associated with housing 36 such that at least a portion of it is contained within or attached to housing 36. Regarding sensor devices / components "associated" with a stent or other implanted structure, such terms may refer to sensor devices or components that are physically coupled, attached, connected, or integrated with the implanted structure.

[0066] In some examples, transducer 32 includes a piezoresistive strain gauge or components thereof, which can be configured to use a bonded or molded strain gauge to detect strain caused by applied pressure, wherein the resistance increases as the pressure deforms the component / material. Transducer 32 can incorporate any type of material, including but not limited to silicon (e.g., single crystal), polycrystalline silicon thin films, bonded metal foils, thick films, silicon-on-sapphire, sputtered thin films, etc.

[0067] In some examples, transducer 32 includes a capacitive pressure sensor or a component thereof, which includes a diaphragm and a pressure chamber configured to form a variable capacitor to detect strain caused by pressure applied to the diaphragm. The capacitance of the capacitive pressure sensor typically decreases as pressure deforms the diaphragm. The diaphragm may comprise any one or more materials, including but not limited to metals, ceramics, silicon, etc. In some examples, transducer 32 includes an electromagnetic pressure sensor or a component thereof, which may be configured to measure diaphragm displacement by means of changes in inductance, linear variable displacement transducer (LVDT) functionality, Hall effect, or eddy current sensing. In some examples, transducer 32 includes a piezoelectric strain sensor or a component thereof. For example, such a sensor may determine strain (e.g., pressure) on a sensing mechanism based on the piezoelectric effect in certain materials (such as quartz).

[0068] In some examples, transducer 32 includes a strain gauge or a component of a strain gauge. For example, strain gauge examples may include a pressure-sensitive element on or associated with the exposed surface of transducer 32. In some examples, a metal strain gauge is adhered to the surface of the sensor, or a thin-film strain gauge may be applied to the sensor by sputtering or other techniques. The measuring element or mechanism may include a diaphragm or a metal foil. Transducer 32 may include any other type of sensor or pressure sensor, such as an optical sensor, a potential sensor, a resonant sensor, a thermal sensor, an ionization sensor, or other type of strain or pressure sensor.

[0069] Figure 5 A system 40 for monitoring one or more physiological parameters (e.g., left atrial pressure and / or volume) of a patient 44 is illustrated according to one or more examples. The patient 44 may have a medical implantable device 30 implanted, for example, in the heart (not shown) of the patient 44 or in related physiology. For example, the implantable device 30 may be implanted at least partially within the left atrium and / or coronary sinus of the patient's heart. The implantable device 30 may include one or more sensor transducers 32, such as one or more microelectromechanical systems (MEMS) devices (e.g., MEMS pressure sensors or other types of sensor transducers).

[0070] In some examples, the monitoring system 40 may include at least two subsystems, including an implantable internal subsystem or a device 30 including one or more sensor transducers 32, and control circuitry 34 including one or more microcontrollers, one or more discrete electronic components, and one or more power and / or data transmitters 38 (e.g., antenna coils). The monitoring system 40 may further include an external (e.g., non-implantable) subsystem including an external reader 42 (e.g., a coil), which may include a wireless transceiver electrically and / or communicatively coupled to some control circuitry 41. In some examples, both the internal subsystem 30 and the external subsystem 42 include corresponding coil antennas for wireless communication and / or power delivery through patient tissue disposed therebetween. The sensor implantation device 30 may be any type of implantation device. For example, in some examples, the implantation device 30 includes a pressure sensor integrated with another functional implantation structure 39, such as a prosthetic shunt or stent device / structure.

[0071] Certain details of the implantation device 30 are shown in the enlarged box 30. The implantation device 30 may include an implantation / anchor structure 39 as described herein. For example, the implantation / anchor structure 39 may include a percutaneously deliverable shunt device configured to be fixed to and / or within a tissue wall to provide a flow path between two chambers of the heart and / or blood vessels, as described in detail throughout this disclosure. Although some components are... Figure 5 The sensor implantation device 30 is illustrated as part of the implantation device 30, but it should be understood that the sensor implantation device 30 may include only a subset of the illustrated components / modules and may include additional components / modules not shown. The implantation device may represent... Figure 4 The example of the implantable device shown is, conversely, illustrated. The implantable device 30 may advantageously include one or more sensor transducers 32, which may be configured to provide a response indicative of one or more physiological parameters of the patient 44, such as atrial pressure. Although a pressure transducer is described, the one or more sensor transducers 32 may include one or more suitable or desired types of sensor transducers for providing signals related to physiological parameters or conditions associated with the implantable device 30 and / or the patient 44.

[0072] One or more sensor transducers 32 may include one or more MEMS sensors, optical sensors, piezoelectric sensors, electromagnetic sensors, strain sensors / strain gauges, accelerometers, gyroscopes, diaphragm-based sensors, and / or other types of sensors, which may be positioned within the patient 44 to sense one or more parameters related to the patient's health. The transducer 32 may be a force-harvesting type pressure sensor. In some examples, the transducer 32 includes a diaphragm, piston, Bourdon tube, bellows, or one or more other strain or deflection measuring components to measure strain or deflection applied to its area / surface. The transducer 32 may be associated with a sensor housing 36 such that at least a portion of it is contained within or attached to the housing 36.

[0073] In some examples, transducer 32 includes a strain gauge or a component of a strain gauge, which can be configured to detect strain caused by applied pressure using a bonded or molded strain gauge. For example, transducer 32 may include a piezoresistive strain gauge or a component of a piezoresistive strain gauge, wherein the resistance increases as pressure deforms the component / material of the strain gauge. Transducer 32 can incorporate any type of material, including but not limited to silicone resins, polymers, silicon (e.g., single crystal), polycrystalline silicon thin films, bonded metal foils, thick films, silicon-on-sapphire, sputtered thin films, etc. In some examples, a metal strain gauge is adhered to the sensor surface, or a thin-film strain gauge can be applied to the sensor by sputtering or other techniques. The measuring element or mechanism may include a diaphragm or metal foil. Transducer 32 may include any other type of sensor or pressure sensor, such as an optical sensor, a potential sensor, a resonant sensor, a thermal sensor, an ionization sensor, or other type of strain or pressure sensor.

[0074] In some examples, transducer 32 includes a capacitive pressure sensor or a component thereof, which includes a diaphragm and a pressure chamber configured to form a variable capacitor to detect strain caused by pressure applied to the diaphragm. The capacitance of the capacitive pressure sensor typically decreases as pressure deforms the diaphragm. The diaphragm may comprise any one or more materials, including but not limited to metals, ceramics, silicone, silicon, or other semiconductors. In some examples, transducer 32 includes an electromagnetic pressure sensor or a component thereof, which may be configured to measure diaphragm displacement by means of changes in inductance, linear variable displacement transducer (LVDT) functionality, Hall effect, or eddy current sensing. In some examples, transducer 32 includes a piezoelectric strain sensor or a component thereof. For example, such a sensor may determine strain (e.g., pressure) on a sensing mechanism based on the piezoelectric effect in certain materials, such as quartz.

[0075] In some examples, one or more transducers 32 are electrically and / or communicatively coupled to control circuitry 34, which may include one or more application-specific integrated circuit (ASIC) microcontrollers or chips. Control circuitry 34 may further include one or more discrete electronic components, such as tuning capacitors, resistors, diodes, inductors, etc.

[0076] In some examples, one or more sensor transducers 32 may be configured to generate electrical signals that can be wirelessly transmitted to a device outside the patient's body, such as the local external monitoring system 42 shown. To perform this wireless data transmission, the implantable device 30 may include radio frequency (RF) (or other frequency band) transmission circuitry, such as signal processing circuitry and an antenna 38. The antenna 38 may include an antenna coil implanted within the patient's body. The control circuitry 34 may include any type of transceiver circuitry configured to transmit electromagnetic signals, which may be radiated by the antenna 38, which may include one or more wires, coils, plates, etc. The control circuitry 34 of the implantable device 30 may include, for example, one or more chips or dies configured to perform a certain amount of processing on signals generated and / or transmitted using the device 30. However, due to size, cost, and / or other limitations, the implantable device 30 may not include independent processing capabilities in some examples.

[0077] The wireless signals generated by the implanted device 30 can be received by a local external monitoring device or subsystem 42, which may include a reader / antenna interface circuit module 43 configured to receive wireless signal transmissions from the implanted device 30, which is at least partially disposed within the patient 44. For example, module 43 may include one or more transceiver devices / circuits.

[0078] The external local monitor 42 can receive wireless signal transmissions from the implanted device 30 and / or provide wireless power to the implanted device 30 using an external antenna 48 (such as a stick device). The reader / antenna interface circuit 43 may include radio frequency (RF) (or other frequency band) front-end circuitry configured to receive and amplify signals from the implanted device 30. This circuitry may include one or more filters (e.g., bandpass filters), amplifiers (e.g., low-noise amplifiers), analog-to-digital converters (ADCs) and / or digital control interface circuitry, phase-locked loop (PLL) circuitry, signal mixers, etc. The reader / antenna interface circuit 43 may be further configured to transmit signals to a remote monitoring subsystem or device 46 via a network 49. The RF circuitry of the reader / antenna interface circuit 43 may further include one or more of a digital-to-analog converter (DAC) circuitry, a power amplifier, a low-pass filter, an antenna switch module, an antenna, etc., for treating / processing signals transmitted via the network 49 and / or for receiving signals from the implanted device 30. In some examples, the local monitor 42 includes control circuitry 41 for performing processing of signals received from the implanted device 30. Local monitor 42 can be configured to communicate with network 49 according to known network protocols such as Ethernet, Wi-Fi, etc. In some examples, local monitor 42 includes a smartphone, laptop computer, or other mobile computing device or any other type of computing device.

[0079] In some examples, the implantable device 30 includes a quantity of volatile and / or non-volatile data storage. For example, such data storage may include solid-state memory utilizing a floating-gate transistor array, etc. The control circuitry 34 may utilize the data storage to store sensing data collected over a period of time, wherein the stored data may be periodically transmitted to a local monitor 42 or other external subsystems. In some examples, the implantable device 30 does not include any data storage. The control circuitry 34 may be configured to facilitate the wireless transmission of data generated by one or more sensor transducers 32 or other data associated therewith. The control circuitry 34 may be further configured to receive input from one or more external subsystems, such as from a local monitor 42, or from a remote monitor 46, such as on a network 49. For example, the implantable device 30 may be configured to receive signals that at least partially control the operation of the implantable device 30, such as by activating / deactivating one or more components or sensors, or otherwise influencing the operation or performance of the implantable device 30.

[0080] One or more components of the implantable device 30 may be powered by one or more power sources 35. Due to considerations of size, cost, and / or electrical complexity, it may be desirable for the power source 35 to be inherently relatively simple. For example, high-power drive voltages and / or currents in the implantable device 30 may adversely affect or interfere with the operation of the heart or other body parts associated with the implantable device. In some examples, the power source 35 is inherently at least partially passive, allowing it to wirelessly receive power from an external source via passive circuitry of the implantable device 30, such as through the use of short-range or near-field wireless power transfer or other electromagnetic coupling mechanisms. For example, a local monitor 42 may act as an initiator of an actively generated RF field that can power the implantable device 30, thereby allowing the power circuitry of the implantable device to employ a relatively simple form factor. In some examples, the power source 35 may be configured to harvest energy from environmental sources, such as fluid flow, motion, etc. Additionally or alternatively, the power source 35 may include a battery that may be advantageously configured to provide sufficient power during the monitoring period (e.g., 3, 5, 10, 20, 30, 40, or 90 days, or any other time period).

[0081] In some examples, the local monitoring device 42 can serve as an intermediate communication device between the implanted device 30 and the remote monitor 46. The local monitoring device 42 can be a dedicated external unit designed to communicate with the implanted device 30. For example, the local monitoring device 42 can be a wearable communication device or other devices that can be easily placed near the patient 44 and the implanted device 30. The local monitoring device 42 can be configured to continuously, periodically, or intermittently query the implanted device 30 to extract or request sensor-based information. In some examples, the local monitor 42 includes a user interface through which a user can view sensor data, request sensor data, or otherwise interact with the local monitoring system 42 and / or the implanted device 30.

[0082] System 40 may include an auxiliary local monitor 47, which may be, for example, a desktop computer or other computing device, configured to provide a monitoring station or interface for viewing and / or interacting with the monitored cardiac pressure data. In one example, local monitor 42 may be a wearable device or other device or system configured to be physically close to the patient and / or implanted device 30, wherein local monitor 42 is primarily designed to receive / send signals from / to implanted device 30 and provide these signals to auxiliary local monitor 47 for viewing, processing, and / or manipulation. External local monitoring system 42 may be configured to receive and / or process certain metadata from or associated with implanted device 30, such as device ID, which may also be provided via data coupling from implanted device 30.

[0083] The remote monitoring subsystem 46 can be any type of computing device or collection of computing devices configured to receive, process, and / or present monitoring data received via network 49 from local monitoring device 42, auxiliary local monitor 47, and / or implanted device 30. For example, the remote monitoring subsystem 46 can advantageously be operated and / or controlled by a healthcare entity such as a hospital, physician, or other care entity associated with patient 44. While some examples disclosed herein describe communication between the implanted device and the remote monitoring subsystem 46 indirectly via local monitoring device 42, in some examples, the implanted device 30 may include a transmitter capable of communicating with the remote monitoring subsystem 46 via network 49 without relaying information through local monitoring device 42.

[0084] In some examples, at least a portion of the transducer 32, control circuitry 34, power supply 35, and / or antenna 38 is at least partially disposed within or contained in a sensor housing 36, which may comprise any type of material and may advantageously be at least partially sealed. For example, in some examples, housing 36 may comprise glass or other rigid materials, which may provide mechanical stability and / or protection for the components housed therein. In some examples, housing 36 is at least partially flexible. For example, housing may comprise polymers or other flexible structures / materials, which may advantageously allow folding, bending, or collapse of the sensor 37 to allow its delivery via a conduit or other percutaneous introduction device.

[0085] As described above, shunts and other implantable devices / structures can be integrated with sensors, antennas / transceivers, and / or other components to facilitate in vivo monitoring of pressure and / or one or more other physiological parameters. Sensor devices according to examples of this disclosure can be integrated with cardiac shunt structures / devices or other implantable devices using any suitable or desired attachment or integration mechanism or construction. Figure 6 An example sensor assembly / device 60 is illustrated, which may be a component of a sensor implantation device. The sensor device 60 may be configured to provide sensor readings related to one or more physiological parameters associated with a target implantation site.

[0086] The sensor device 60 can be configured to attach to an implantable device. For example, a coil form comprising one or more wires or one or more windings shaped as a coil can be used to attach the sensor device 60 to one or more implants, the coil forming a fluid conduit / cylindrical portion and an axial end flange. According to certain examples disclosed herein, a shunt structure can be integrated with pressure sensor functionality. The shunt structure can be configured to retain the sensor device 60.

[0087] The sensor device 60 can be advantageously positioned, located, fixed, oriented, and / or otherwise positioned within a configuration in which its sensor transducer component 65 is disposed within the channel region of the flow divider structure. The term “channel region” is used herein in its broad and general sense and can refer to a three-dimensional space defined by the radial boundary of the fluid conduit and extending axially from the fluid conduit.

[0088] In some examples, sensor assembly 61 includes sensor component 65 and antenna component 69. Sensor component 65 may include any type of sensor device as described in detail above. In some examples, sensor 65 may be attached to or integrated with the arm component of the shunt structure.

[0089] Sensor 65 includes sensor elements 67, such as pressure sensor transducers. As described herein, sensor assembly 61 can be configured to enable wireless data and / or power transmission. Sensor assembly 61 may include an antenna component 69 for this purpose. Antenna 69 may be at least partially contained within an antenna housing 79, which may further contain certain control circuitry configured to facilitate wireless data and / or power communication functions. In some examples, antenna component 69 includes one or more conductive coils 62 that may facilitate inductive power supply and / or data transmission. In examples including one or more conductive coils, such one or more coils may be at least partially wound / arranged around a magnetic (e.g., ferrite, iron) core 63.

[0090] Antenna component 69 may be attached to, integrated with, or otherwise associated with the arm / anchor feature of the shunt structure.

[0091] Sensor assembly 61 can advantageously be biocompatible. For example, sensor 65 and antenna 69 may include biocompatible housings, such as housings comprising glass or other biocompatible materials. However, in some examples, at least a portion of sensor element 67, such as a diaphragm or other component, may be exposed to the external environment to allow for pressure readings or other parameter sensing. Regarding antenna housing 79, housing 79 may include at least partially rigid cylindrical or tubular forms, such as glass cylinders. In some examples, the diameter of sensor 65 / 67 components is approximately 3 mm or less. The length of antenna 69 may be approximately 20 mm or less.

[0092] Sensor assembly 61 can be configured to communicate with external systems when implanted in a patient's heart or other area of ​​the body. For example, antenna 69 can wirelessly receive power from and / or transmit sensed data or waveforms to and / or from the external system. Sensor assembly 61 can be attached to or integrated with the shunt structure in any suitable or desired manner. For example, in some embodiments, sensor 65 and / or antenna 69 can be attached to or integrated with the shunt structure using mechanical connection means. In some examples, sensor 65 and / or antenna 69 can be contained in a bag or other container attached to the shunt structure.

[0093] Sensor element 67 may include a pressure transducer. For example, the pressure transducer may be a microelectromechanical system (MEMS) transducer that includes a semiconductor diaphragm component. In some examples, the transducer may include at least partially flexible or compressible diaphragm components, which may be made of silicone or other flexible materials. The diaphragm components may be configured to bend or compress in response to changes in ambient pressure.

[0094] Heart implants

[0095] Figure 7 The illustration shows an example shunt / anchor structure 150, which can be configured to be attached to one or more sensor devices according to one or more examples. The shunt structure 150 may represent a cardiac implant that can be integrated with pressure sensor functionality (e.g., with certain examples disclosed herein) according to some of the examples disclosed herein. Figure 4 An example of an associated anchor and / or cardiac implant structure (or 5). The shunt structure 150 may be a deployable shunt. When deployed, the central flow channel 166 of the shunt 150 may define a generally circular or oval opening and / or form a fluid conduit when positioned within an orifice in a tissue wall. The channel 166 may be configured to retain the sides of the puncture opening and / or other orifices within the tissue wall to form a blood flow path between one or more chambers of the heart or one or more vessels separated by the tissue wall. For example, the shunt 150 may be configured to be implanted in a wall separating the coronary sinus and the left atrium to form a fluid conduit between the coronary sinus and the left atrium. The central flow channel 166 may be partially formed by a pair of sidewalls 170a, 170b defined by a generally parallel arrangement of thin struts 179 forming a parallelogram unit or an array of openings 180. In some examples, essentially the entire shunt 150 is formed of hyperelastic struts configured to be compressed and fitted into a conduit (not shown) and subsequently unfolded back as shown. Figure 7 The relaxed shape shown.

[0096] The use of multiple interconnected struts forming units therebetween to form a shunt 150 can at least partially increase the flexibility of the shunt, allowing it to compress and expand at the implantation site. The interconnected struts surrounding the central flow channel 166 advantageously provide a cage with sufficient rigidity and structure to hold tissue at the puncture site in an open position. The end walls 172a, 172b of the central flow channel 166 can be used to connect the side walls 170a, 170b and extend between the distal and proximal flanges or arms 152, 154 on each side. As shown, the side walls 170a, 170b and the end walls 172a, 172b together can define a tubular lattice. The end walls 172a, 172b may include thin struts 179 extending at a small angle from the central flow axis of the shunt 150. The shunt 150 may further include the terminals (160a, 164a, 160b, 164b) of arms 152, 154, which may be closer to the ends of the end walls 172a, 172b of arms 152, 154 than the ends of the arms 152, 154 connected to the end walls 172a, 172b.

[0097] Although the illustrated diverter 150 includes struts defining a tubular or circular grid of open units forming a central flow channel 166, in some examples, the structure constituting the channel forms a substantially continuous wall surface extending through at least a portion of the channel 166. In the illustrated example, the tilting of the diverter structure 150 can facilitate collapse into a delivery catheter (not shown) and deployment of flanges / arms 152, 154 on either side of the target tissue wall. The diverter 150 may include a first left arm 152a, a second left arm 154a, a first right arm 152b, and / or a second right arm 154b. The central flow channel 166 can remain substantially unchanged between a collapsed state and a deployed state of the diverter 150, while the flanges / arms 152, 154 can be switched between alignment and misalignment with the angled flow channel.

[0098] While some examples of the flow dividers disclosed herein include flow channels and / or fluid conduits with generally circular cross-sections, in some examples, the flow divider structures according to this disclosure have oval, rectangular, rhomboid, or elliptical flow channel configurations. For example, with Figure 7 Compared to the configuration shown, relatively elongated sidewalls can create rectangular or oval flow channels. This shape of flow channel may be suitable for larger perforations, while still being configured to collapse into a relatively small delivery profile.

[0099] In some examples, each of the distal and proximal flanges / arms 152, 154 is configured to curl outward from the end walls 172a, 172b and is positioned generally radially away from the central flow channel 166 in the deployed configuration. The deployed flanges / arms can be used to secure the shunt 150 to a target tissue wall. Other aspects and features of shunts, implants, and / or anchor structures that can be integrated with the sensor devices / functions of the examples of this disclosure are disclosed in U.S. Patent No. 9,789,294, entitled "Deployable Cardiac Shunt," published October 17, 2017, the disclosure of which is expressly incorporated herein by reference in its entirety. Although this document is similar to Figure 7 Certain examples are disclosed in the context of the shunt structures shown and described above, but it should be understood that shunt structures or other implantable devices integrated with pressure sensor functionality according to examples of this disclosure may have any type, form, structure, construction and / or be usable or constructed for any purpose, whether for shunt or other purpose or function.

[0100] Figure 8 A shunt implant / anchoring device / structure 73 is shown in an implanted atrial septum 18 according to one or more examples. Although Figure 8 The shunt implant is described herein, but implant 73 can be any of the various implants described herein. A specific location within the atrial septal wall 18 can be selected or defined to provide a relatively safe anchoring location for the shunt structure 73. Furthermore, the shunt device / structure 73 can be implanted at an ideal location with consideration for future re-crossing of the septal wall 18 for future intervention. Implantation of the shunt device / structure 73 within the atrial septal wall 18 can advantageously allow fluid communication between the left atrium 2 and the right atrium 5.

[0101] Atrial shunts using shunt devices / structures 73 may be ideal for patients who are relatively highly sensitive to increases in atrial pressure. For example, as pressure increases in the ventricles and / or atria and acts on the cardiomyocytes, the heart muscle may often tend to contract relatively less effectively to handle excess blood. Therefore, patients with impaired ventricular contractility may become more sensitive to higher pressures in the ventricles and / or atria as the heart may not be able to adequately respond to them, especially with ventricular enlargement or stretching. Furthermore, increased left atrial pressure can lead to dyspnea, and thus may require atrial shunts to reduce left atrial pressure to decrease dyspnea and / or reduce readmission rates. For example, when the ventricles are dysfunctional and unable to adapt to increased fluid pressure, this fluid may flow back into the atria, increasing atrial pressure. For heart failure, minimizing left ventricular end-diastolic pressure may be paramount. Because left ventricular end-diastolic pressure can be correlated with left atrial pressure, fluid accumulation in the atria can lead to fluid accumulation in the lungs, resulting in undesirable and / or dangerous pulmonary effusion. Atrial shunts, such as those using shunt devices according to examples of this disclosure, can transfer additional fluid from the left atrium to the right atrium, which may be able to accommodate the additional fluid due to the relatively high compliance in the right atrium.

[0102] In some embodiments, the shunt device / structure according to the examples of this disclosure can be implanted in the wall separating the coronary sinus from the left atrium, so that atrial shunt can be achieved through the coronary sinus. Figure 9 A shunt device / structure 83 is shown implanted in the tissue wall 21 between the coronary sinus 16 and the left atrium 2. Although Figure 9 The shunt implant is described herein, but implant 83 can be any of the various implants described herein. Figure 9 And some of the images below show a portion of the heart from top to bottom from a superior perspective, facing the top of the page.

[0103] In some cases, shunts from left to right are better achieved by implanting a shunt device 83 in the wall 21 between the left atrium 2 and the coronary sinus 16 than by shunts through the atrial septum. For example, shunts through the coronary sinus 16 can reduce the risk of thrombi and emboli. Thrombi / emboli are unlikely to occur in the coronary sinus for several reasons. First, the blood flowing from the coronary system into the right atrium 5 has just passed through capillaries, so it is essentially filtered blood. Second, the coronary sinus ostium 14 in the right atrium is partially covered by a pseudovalve portion (not shown), commonly referred to as the coronary sinus valve. The coronary sinus valve is not always present, but some studies suggest it is present in most hearts and can prevent thrombi or other emboli from entering in the event of increased pressure in the right atrium. Third, the pressure gradient between the coronary sinus and the right atrium into which it drains is generally relatively low, making it more likely that thrombi or other emboli in the right atrium will remain there. Fourth, in the event that a thrombus / emboli does enter the coronary sinus, the gradient between the right atrium and the coronary system will be much greater than the gradient between the right atrium and the left atrium. Most likely, the thrombus / embolus will travel further down the coronary system until the pressure in the right atrium returns to normal, at which point the embolus will return directly to the right atrium.

[0104] Some additional advantages of positioning the shunt structure 83 between the left atrium and the coronary sinus are that this anatomical structure is generally more stable than the atrial septum tissue. By diverting blood from the left atrium to the coronary sinus, sinus pressure may increase slightly. This will cause blood in the coronary system to flow through the heart more slowly, thereby increasing perfusion and oxygen transfer, which can be more efficient and may also help recover dying myocardium. Furthermore, by implanting the shunt device / structure 83 in the wall of the coronary sinus, damage to the atrial septum 18 can be prevented. Therefore, the atrial septum 18 can be preserved for later transseptal access for replacement therapy. Preserving transseptal access may be advantageous for various reasons. For example, patients with heart failure often have many other comorbidities, such as atrial fibrillation and / or mitral regurgitation; some treatments for these conditions require transseptal access.

[0105] It should be noted that, in addition to the various benefits of placing the implant / structure 83 between the coronary sinus 16 and the left atrium 2, certain disadvantages can also be considered. For example, by shunting blood from the left atrium 2 to the coronary sinus 16, oxygenated blood from the left atrium 2 can be diverted to the right atrium 5 and / or anaerobic blood from the right atrium 5 can be diverted to the left atrium 2, both of which may be undesirable for normal cardiac function.

[0106] Sensor implantation device

[0107] Figure 10A and 10B An example sensor implantation device 1000 according to one or more examples of this disclosure is illustrated. Figure 10A A top view of an example sensor implantation device 1000 is provided, which includes a sensor 1004 coupled to at least a portion of the implant 1000 (e.g., a shunt body 1007 and / or a cylindrical portion). The term "shunt body" is used herein according to its simple and general meaning and may refer to the body portion of the sensor implantation device 1000 and / or the portion of the sensor implantation device 1000 configured to be at least partially placed within a shunt opening (i.e., an aperture) and / or through an orifice in the tissue wall. In some examples, the various shunt bodies 1007 described herein may be configured to maintain the shunt opening (e.g., by preventing inward growth at the opening). The shunt body 1007 may have a generally tubular and / or cylindrical form and / or a partially tubular and / or partially cylindrical form. Figure 10B A side view of an example sensor implantation device 1000 is provided. The sensor 1004 described herein can be coupled to the shunt body 1007 in any of a variety of ways. For example, an arm 1005, which may include one or more cords, wires, tethers, and / or similar devices, may extend from and / or be coupled to the shunt body 1007 and / or the sensor device 1004. In some examples, the arm 1005 may be coupled to and / or may extend into one or more coils 1113 configured to at least partially wind around at least a portion of the sensor device 1004 to form a secure attachment between the arm 1005 and the sensor device 1004. For example, the arm 1005 may include cords configured to extend between the sensor 1004 and the shunt body 1007 and / or be configured to at least partially wind around the sensor 1004 to form a secure attachment to the sensor 1004. In some examples, sensor 1004 may be coupled to shunt body 1007 via one or more arms 1005.

[0108] In some examples, the sensor implantation device 1000 and / or shunt body 1007 described herein may be configured to provide a fluid conduit through an opening and / or orifice in the tissue wall within the heart. For example, the shunt body 1007 may be configured to be at least partially placed within an opening in the tissue wall between the coronary sinus and the left atrium of the heart. The opening may be formed via a tissue puncture procedure. In some examples, the shunt body 1007 may be configured to maintain the opening and / or prevent tissue growth across the opening. Blood flow between the left atrium and the coronary sinus may be allowed to pass through at least a portion of the shunt body 1007 and / or through the opening.

[0109] The sensor device 1004 can be configured to collect any of a variety of measurements related to blood flow at or near the sensor implantation device 1000. For example... Figure 10A and 10B As shown, sensor device 1004 can be configured to be at least partially positioned above the cavity 1015 of shunt body 1007. For example, shunt body 1007 can have at least a partially cylindrical form. Sensor device 1004 can be at least partially positioned above shunt body 1007 such that blood flow through shunt body 1007 can flow along sensor device 1004 and / or sensor device 1004 can be positioned to collect measurements related to blood flow through shunt body 1007 and / or cavity 1015 of sensor implantation device 1000. In some examples, arm 1005 of sensor implantation device 1000 can be at least partially adjustable to allow adjustment of sensor device 1004 placement when sensor device 1004 is at least indirectly coupled to shunt body 1007.

[0110] Figure 11A and 11B An example sensor implantation device 1100 according to one or more examples of this disclosure is illustrated. Figure 11A A top view of an example sensor implantation device 1100 is provided, which includes a sensor 1104 coupled to at least a portion of an implant 1000 (e.g., a shunt body 1107). Figure 11B A side view of an example sensor implantation device 1100 is provided. The sensor 1104 described herein can be coupled to the shunt body 1107 in any of a variety of ways. For example, an arm 1105, which may include one or more cords, wires, tethers, and / or similar devices, may extend from and / or be coupled between the shunt body 1107 and / or the sensor device 1104. In some examples, the arm 1105 may be coupled to and / or may extend into one or more coils 1113 configured to at least partially wrap around at least a portion of the sensor device 1104 to form a secure attachment between the arm 1105 and the sensor device 1104. For example, the arm 1105 may include cords configured to extend between the sensor 1104 and the shunt body 1107 and / or be configured to at least partially wrap around the sensor 1104 to form a secure attachment to the sensor 1104.

[0111] In some examples, the sensor implantation device 1100 and / or shunt body 1107 described herein can be configured to provide a fluid conduit through an opening and / or orifice in the tissue wall within the heart. For example, the shunt body 1107 can be configured to be at least partially placed within an opening in the tissue wall between the coronary sinus and the left atrium of the heart. The opening can be formed via a tissue puncture procedure. In some examples, the shunt body 1107 can be configured to maintain the opening and / or prevent tissue growth across the opening. Blood flow between the left atrium and the coronary sinus can be allowed to pass through at least a portion of the shunt body 1107.

[0112] The sensor device 1104 can be configured to collect any of a variety of measurements related to blood flow at or near the sensor implantation device 1100. For example... Figure 11A and 11B As shown, sensor device 1104 can be configured to be positioned at least partially offset from the lumen 1115 and / or shunt body 1007 of sensor implantation device 1100. For example, sensor device 1004 may be at least partially located outside the blood flow pathway through the lumen 1115 and / or shunt body 1007 of sensor implantation device 1100 and / or may not be fully positioned above the lumen 1115. Measurements collected by sensor device 1004 thus reflect the blood flow characteristics in one chamber of the heart and / or may not directly indicate blood flow through sensor implantation device 1100. In some examples, arm 1105 of sensor implantation device 1100 may be at least partially adjustable to allow adjustment of the placement of sensor device 1104 (e.g., via one or more arms 1105) when sensor device 1104 is at least indirectly coupled to shunt body 1007.

[0113] Figure 12A and 12BThe illustration shows a sensor implantation device 1200 according to one or more examples, which includes a sensor 1204 coupled to and / or extending from a shunt body 1203. The shunt body 1203 may be configured to position the sensor 1204 in a desired location and / or securely hold the sensor 1204 in place. In some examples, the shunt body 1203 may include a wire loop having a first end 1226 configured to engage and / or attach to the sensor 1204 at a first point, and / or the shunt body 1203 may include a second end 1227 configured to attach and / or engage to the sensor 1204 at a second point. In some examples, the splitter body 1203 may have a "mushroom" shape, wherein a first portion 1207 of the splitter body 1203 has a first width and / or diameter and / or wherein a second portion 1209 of the splitter body 1203 expands to a second width and / or diameter greater than the first width and / or diameter. Although Figure 12A and 12B The shunt body 1203 shown includes a single line, but the shunt body 1203 may include any number of lines and / or may include forming lines. Figure 12A and 12B The image depicts a network of mushroom-shaped lines. For example, the shunt body 1203 may include multiple lines that may overlap and / or intersect at various points and / or may be spread out in different planes relative to the sensor 1204. In some examples, the shunt body 1203 may form a coil 1213 around at least a portion of the sensor 1204.

[0114] In some examples, the shunt body 1203 may be at least partially made of one or more shape memory alloys (e.g., nitinol) and / or may be configured to naturally emerge when removed from the conduit and / or other delivery device. Figure 12A The form shown is illustrated. For example, the shunt body 1203 may include one or more metal wires shaped as loops. The loops may be configured to be compressed when delivered via catheters and / or other delivery systems. Furthermore, the loops may be configured to present a first width at a first portion 1207 (e.g., within the opening 1214 of the tissue wall 1221 and / or within the central flow portion 1217 of the shunt device 1202) and / or may be configured to extend to a second width at a second portion 1209 (e.g., beyond the opening 1214 of the tissue wall 1221 and / or the second side 1223 and / or beyond the central flow portion 1217).

[0115] Figure 12BA sensor implantation device 1200 is illustrated, positioned at and / or at least partially within an opening 1214 in a tissue wall 1221. A first portion 1207 of a shunt body 1203 may be configured to be at least partially located within the opening 1214 through the tissue wall 1221. For example, the width of the shunt body 1203 at the first portion 1207 may be less than the width of the opening 1214 to allow the shunt body 1203 to pass through the opening 1214. The shunt body 1203 at the second portion 1209 may extend laterally (e.g., parallel and / or nearly parallel to the tissue wall 1221) to have a width exceeding the width of the opening 1214. Therefore, the second portion 1209 of the shunt body 1203 may be configured to prevent the shunt body 1203 from escaping upward through the opening 1214 in the tissue wall 1221. Furthermore, the shunt body 1203 at the second portion 1209 can be configured to extend longitudinally (e.g., perpendicular to the tissue wall 1221) and / or away from the sensor 1204 to securely anchor the shunt body 1203 and / or the sensor 1204 in a suitable position relative to the opening of the tissue wall 1221. For example, the second portion 1209 of one or more anchoring arms can have a suitable height to press against the superior wall 1223 and / or inferior wall 1224 of the coronary sinus 16 and / or other regions of the heart to secure the second portion 1209 and / or the sensor implantation device 1200 in a suitable position in the coronary sinus 16 and / or other regions.

[0116] While the sensor implantation device 1200 can be used independently of other implantation devices in some cases, it can also be used additionally or alternatively in conjunction with one or more additional implantation devices. For example, as Figure 12BAs shown, the sensor implantation device 1200 can be used in conjunction with a shunt implant 1202, which can be configured to form and / or maintain a fluid conduit through an opening 1214 in a tissue wall 1221. The shunt implant 1202 may include one or more anchoring arms configured to anchor to a first side 1222 and / or a second side (i.e., the superior wall 1223 of the coronary sinus 16) of the tissue wall 1221. In some examples, the shunt implant 1202 may include a cylindrical portion 1217 configured to be placed within and / or maintained within the opening 1214. A first portion 1207 of the sensor implantation device 1200 may be configured to pass through and / or at least partially fit within at least a portion of the cylindrical portion 1217 of the shunt implant 1202. The sensor 1204 may be configured to be located at any position relative to the opening 1214 and / or the shunt implant 1202. For example, sensor 1204 may be configured to be located above at least a portion of the cylindrical portion 1217 of shunt implant 1202. However, sensor 1204 may additionally or alternatively be positioned off-center from the opening 1214 of the cylindrical portion 1217 and / or the tissue wall 1221 of shunt implant 1202 and / or may extend at least partially above the tissue wall 1221.

[0117] In some examples, the shunt body 1203 may be configured to extend through the tissue wall 1221 and / or to position and / or extend beyond the opening 1214 and / or first side 1222 of the tissue wall 1221. For example, the sensor 1204 may be at least partially and / or completely located within other chambers of the left atrium 2 and / or the first side 1222 of the tissue wall 1221. At least a portion of the shunt body 1203 (e.g., a second portion 1209) may additionally or alternatively be configured to extend beyond the second side 1223 of the tissue wall 1221 and / or anchored within other blood flow pathways and / or chambers of the coronary sinus 16 and / or the second side 1223 of the tissue wall 1221.

[0118] The sensor implantation device 1200 can be configured for delivery in conjunction with and / or separately from the shunt implant 1202. For example, the sensor implantation device 1200 and the shunt implant 1202 can be delivered during a single delivery procedure. In some examples, the sensor implantation device 1200 can be delivered during a first procedure and the shunt implant 1202 can be delivered during a subsequent procedure. Alternatively, the shunt implant 1202 can be delivered during the first procedure and the sensor implantation device 1200 can be delivered during a subsequent procedure.

[0119] Figures 13A-13DThe illustration shows another sensor implantation device 1300 according to one or more examples, which includes a sensor 1304 coupled to a shunt body 1303 (e.g., a coil and / or wound wire), the shunt body 1303 being configured to hold the sensor 1304 at a desired location within the heart. The shunt body 1303 can be configured to be coupled to the sensor 1304 in any of a variety of ways. For example, the shunt body 1303 can be configured to form one or more wraps and / or coils 1313 around the sensor implant to securely attach to the sensor 1304.

[0120] The shunt body 1303 may include multiple connected devices (e.g., multiple coils and / or coiled wires) or may include a single device (e.g., a single coil and / or coiled wire). The shunt body 1303 may have a variable shape and / or width and / or diameter. For example, the coil implant may include a first portion 1306, a second portion 1307, and / or a third portion 1308. The first portion 1306 may be configured to be positioned above an opening in the tissue wall 1321, and / or may be configured to be at least partially positioned in contact with a first side 1322 of the tissue wall 1321. The first portion 1306 of the shunt body 1303 may have a first width and / or diameter. The second portion 1307 of the shunt body 1303 may be configured to be at least partially positioned within an opening in the tissue wall 1321 and / or may have a second width and / or diameter. The third portion 1308 of the shunt body 1303 may have a third width and / or diameter. The second width and / or diameter may be smaller than the first width and / or diameter of the first portion 1306 and / or smaller than the third width and / or diameter of the third portion 1308. The second portion 1307 of the shunt body 1303 may be configured to be at least partially located within an opening in the tissue wall 1321. The second portion 1307 of the shunt body 1303 may have a generally cylindrical shape to approximate the shape of the opening in the tissue wall 1321. The shunt body 1303 may be configured to extend at the third portion 1308 of the shunt body 1303. The third portion 1308 of the shunt body 1303 may be configured to be located below the opening in the tissue wall and / or may be configured to be positioned to at least partially contact the second side 1323 of the tissue wall 1321 (e.g., the coronary sinus 16 side of the tissue wall 1321). The third portion 1308 of the shunt body 1303 may have any suitable shape; for example, the third portion 1308 may be oval, such as... Figures 13A-13C As shown.

[0121] like Figure 13B As shown, the shunt body 1303 may have a generally tubular and / or hollow form surrounding an inner lumen 1315, configured to allow blood flow through the shunt body 1303. Figure 13BIn the example shown, sensor 1304 can be positioned above cavity 1315. Alternatively, as Figure 13C As shown, sensor 1304 can be at least partially offset from the inner cavity 1315.

[0122] In some examples, the shunt body 1303 may be configured to extend through the tissue wall 1321 and / or to position and / or extend the sensor 1304 beyond the opening 1314 and / or the first side 1322 of the tissue wall 1321. For example, the sensor 1304 may be at least partially and / or completely located within other chambers of the left atrium 2 and / or the first side 1322 of the tissue wall 1321. The shunt body 1303 may additionally or alternatively be configured to extend beyond the second side 1323 of the tissue wall 1321 and / or anchored within other blood flow pathways and / or chambers of the coronary sinus 16 and / or the second side 1323 of the tissue wall 1321.

[0123] In some examples, the shunt body 1303 may be at least partially made of one or more shape memory alloys. For example, the shunt body 1303 may be configured to be molded into a generally linear form during delivery via a delivery device (e.g., a conduit). As the shunt body 1303 exits the conduit, it may be configured to naturally form... Figures 13A-13D The device shown. In some examples, the shunt body 1303 may be configured for delivery after the delivery of the shunt implant 1302.

[0124] While the sensor implantation device 1300 can be used independently of other implantation devices in some cases, it can also be used additionally or alternatively in conjunction with one or more additional implantation devices. For example, as Figure 13DAs shown, the sensor implantation device 1300 can be used in conjunction with a shunt implant 1302, which can be configured to form a fluid conduit through an opening in a tissue wall 1321. The shunt implant 1302 may include one or more anchoring arms configured to anchor to a first side 1322 and / or a second side (i.e., the superior wall 1323 of the coronary sinus 16) of the tissue wall 1321. In some examples, the implant 1302 may include a cylindrical portion 1312 configured to be placed within an opening 1314 and / or configured to form a fluid conduit through the opening 1314. A second portion 1307 of the sensor implantation device 1300 can be configured to pass through at least a portion of the cylindrical portion 1312 of the shunt implant 1302. The sensor 1304 can be configured to be located at any position relative to the opening and / or the shunt implant 1302. For example, sensor 1304 may be configured to be located on at least a portion of the cylindrical portion 1312 of shunt implant 1302. However, sensor 1304 may additionally or alternatively be positioned off-center from the openings of the cylindrical portion 1312 and / or tissue wall 1321 of shunt implant 1302.

[0125] Figure 14-17 The illustration shows at least a portion of a sensor implantation device according to one or more examples, the sensor implantation device being configured to position one or more sensors at or near an opening in the tissue wall. Figure 14 A side view of an example shunt body 1400 including a sensor base 1405 configured to be coupled to and / or otherwise cooperate with one or more sensors is provided. The shunt body 1400 may include a network of one or more wires 1417 and / or struts, which may include cords and / or similar devices. In some examples, the shunt body 1400 may be configured to form a cylindrical portion 1407 having a reduced diameter relative to the ends 1426, 1427 of the shunt body 1400. One or more ends 1426, 1427 may be configured as openings extending beyond the tissue wall and / or openings extending out of the tissue wall and / or the cylindrical portion 1407 may be configured to be at least partially positioned within the openings. In some examples, the splitter body 1400 may have at least a partially curved form and / or may have an "hourglass" shape, such that the diameter of the splitter body 1400 may gradually decrease between the first end 1426 and the cylindrical portion 1407, and / or may gradually increase from the cylindrical portion 1407 to the second end 1427. The diameter and / or width of the splitter body 1400 may increase from a first (e.g., minimum) diameter and / or width at the cylindrical portion 1407 to a second (e.g., maximum) diameter and / or width at the first end 1426 and / or at the second end 1427, which is greater than the first diameter and / or width.

[0126] The shunt body 1400 can have any suitable shape and / or the wire network forming the shunt body 1400 can have any suitable pattern. In some examples, the shunt body 1400 can be at least partially compressible and / or deployable to allow the shunt body 1400 to be in a compressed form while within the delivery device and / or deployed when removed from the delivery device. The shunt body 1400 can be configured to be retractable after delivery. In some examples, the shunt body 1400 can be at least partially made of shape memory alloy and / or can be otherwise configured to... Figure 14 The shape is designed in the form shown so that the diverter body 1400 can be naturally presented after being removed from the delivery device. Figure 14 The shape shown.

[0127] The shunt body 1400 may include one or more units 1419, which may include gaps and / or openings in the wire network 1417 forming the shunt body 1400. The one or more units 1419 may have a rhomboid shape.

[0128] In some examples, the shunt body 1400 may be configured to rotate and / or otherwise adjust after delivery to a desired position relative to the tissue wall. For example, after at least a portion of the shunt body 1400 is placed within an opening through the tissue wall, the shunt body 1400 may be rotated laterally to adjust the position of the sensor base 1405 and / or adjust the position of one or more sensors coupled to the sensor base 1405. Thus, one or more sensors coupled to the shunt body 1400 can be rotated and oriented as needed. In some examples, the sensor base 1405 may be configured to position one or more sensors to extend at least partially over and / or from the cylindrical portion 1407 of the shunt body 1400 to an offset position. Figure 14 As shown, the sensor base 1405 may have a generally circular and / or annular form. However, the sensor base 1405 may have any suitable shape and / or may be configured to provide a platform for placing one or more sensors. In some examples, the sensor base 1405 may be configured to extend away from the cylindrical portion 1407 and / or to be coupled to and / or extended into the sensor base 1405 by one or more wires 1417. The sensor base 1405 may be configured to extend away from the cylindrical portion 1407 to prevent the cylindrical portion 1407 from becoming obstructed.

[0129] The diverter body 1400 may include one or more delivery system attachment features 1409 configured to attach to various delivery devices. For example, attachment feature 1409 may include a ring configured to engage using hooks of the delivery system.

[0130] Figure 15 A side view of an example shunt body 1500 including a sensor base 1505 configured to be coupled to and / or otherwise cooperate with one or more sensors is provided. The shunt body 1500 may include one or more wire networks 1517, which may include cords and / or similar devices. In some examples, the shunt body 1500 may be configured to form a cylindrical portion with a decreasing diameter relative to the ends 1526, 1527 of the shunt body 1500. One or more ends 1526, 1527 may be configured to extend beyond the tissue wall and / or extend out of the tissue wall and / or the cylindrical portion may be configured to be at least partially positioned within the opening. In some examples, the shunt body 1500 may have a at least partially curved form and / or may have an hourglass shape, such that the diameter of the shunt body 1500 may gradually decrease between the first end 1526 and the cylindrical portion, and / or gradually increase from the cylindrical portion to the second end 1527. The splitter body 1500 may include an inner cavity 1515 passing through a cylindrical portion and / or ends 1526, 1527 of the splitter body 1500.

[0131] The shunt body 1500 can have any suitable shape and / or the wire network forming the shunt body 1500 can have any suitable pattern. In some examples, the shunt body 1500 can be at least partially compressible and / or deployable to allow the shunt body 1500 to be in a compressed form while within the delivery device and / or deployed when removed from the delivery device. The shunt body 1500 can be configured to be retractable after delivery. In some examples, the shunt body 1500 can be at least partially made of shape memory alloy and / or can be otherwise configured to... Figure 15 The shape is designed in the form shown so that the diverter body 1500 can be naturally presented after being removed from the delivery device. Figure 15 The shape shown.

[0132] The shunt body 1500 may include one or more units 1519, which may include gaps and / or openings in the wire network 1517 forming the shunt body 1500. The one or more units 1519 may have a rhomboid shape.

[0133] In some examples, the shunt body 1500 may be configured to rotate and / or otherwise adjust after delivery to a desired position relative to the tissue wall. For example, after at least a portion of the shunt body 1500 is placed within an opening through the tissue wall, the shunt body 1500 may be rotated laterally to adjust the position of the sensor base 1505 and / or adjust the position of one or more sensors coupled to the sensor base 1505. Thus, one or more sensors coupled to the shunt body 1500 can be rotated and oriented as needed. In some examples, the sensor base 1505 may be configured to position one or more sensors extending at least partially over and / or from the cylindrical portion of the shunt body 1500 to an offset position. The sensor base 1505 may have, for example, […]. Figure 15 The sensor base 1505 is generally circular in shape. However, the sensor base 1505 can have any suitable shape and / or can be configured to provide a platform for placing one or more sensors. In some examples, the sensor base 1505 can be configured to extend away from the cylindrical portion and / or connected to and / or extended into the sensor base 1505 by one or more wires 1517. The sensor base 1505 can be configured to extend away from the cylindrical portion to prevent obstruction of the cylindrical portion.

[0134] The diverter body 1500 may include one or more delivery system attachment features 1509 (e.g., protrusions, hooks, studs, notches, rings, etc.) configured to attach to various delivery devices. For example, attachment feature 1509 may include a ring configured to engage using hooks of the delivery system.

[0135] Figure 16A top view of an example shunt body 1600 including a sensor base 1605 configured to be coupled to and / or otherwise cooperate with one or more sensors is provided. The shunt body 1600 may include a network of one or more wires 1617, which may include cords and / or similar devices. In some examples, the shunt body 1600 may be configured to form a cylindrical portion with a decreasing diameter relative to the ends 1626, 1627 of the shunt body 1600. One or more ends 1626, 1627 may be configured to extend beyond the tissue wall and / or extend out of the tissue wall and / or the cylindrical portion may be configured to be at least partially positioned within the opening. In some examples, the shunt body 1600 may have a at least partially curved form and / or may have an hourglass shape, such that the diameter of the shunt body 1600 may gradually decrease between the first end 1626 and the cylindrical portion, and / or gradually increase from the cylindrical portion to the second end 1627. The splitter body 1600 may include an inner cavity 1615 passing through a cylindrical portion and / or ends 1626, 1627 of the splitter body 1600.

[0136] The shunt body 1600 may have any suitable shape and / or the wire network forming the shunt body 1600 may have any suitable pattern. In some examples, the shunt body 1600 may be at least partially compressible and / or deployable to allow the shunt body 1600 to be in a compressed form while within the delivery device and / or deployed when removed from the delivery device. The shunt body 1600 may be configured to be retractable after delivery. In some examples, the shunt body 1600 may be at least partially made of shape memory alloy and / or may be otherwise configured to... Figure 16 The shape is designed in the form shown so that the diverter body 1600 can be naturally presented after being removed from the delivery device. Figure 16 The shape shown.

[0137] The shunt body 1600 may include one or more units 1619, which may include gaps and / or openings in the wire network 1617 forming the shunt body 1600. The one or more units 1619 may have a rhomboid shape.

[0138] In some examples, the shunt body 1600 may be configured to rotate and / or otherwise adjust after delivery to a desired position relative to the tissue wall. For example, after at least a portion of the shunt body 1600 is placed within an opening through the tissue wall, the shunt body 1600 may be rotated laterally to adjust the position of the sensor base 1605 and / or adjust the position of one or more sensors coupled to the sensor base 1605. Thus, one or more sensors coupled to the shunt body 1600 can be rotated and oriented as needed. In some examples, the sensor base 1605 may be configured to position one or more sensors extending at least partially over and / or from the cylindrical portion of the shunt body 1600 to an offset position. The sensor base 1605 may have, for example, […]. Figure 16 The sensor base 1605 is generally circular in shape. However, the sensor base 1605 can have any suitable shape and / or can be configured to provide a platform for placing one or more sensors. In some examples, the sensor base 1605 can be configured to extend away from the cylindrical portion and / or connected to and / or extend into the sensor base 1605 via one or more wires 1617. The sensor base 1605 can be configured to extend away from the cylindrical portion to prevent obstruction of the cylindrical portion.

[0139] The diverter body 1600 may include one or more delivery system attachment features 1609 configured to attach to various delivery devices. For example, attachment feature 1609 may include a ring configured to engage using hooks of the delivery system.

[0140] Figure 17 The illustration depicts an example sensor implantation system including a shunt implant 1702 and a shunt body according to one or more examples. The shunt body may include one or more wire networks, which may include cords and / or similar devices. In some examples, the shunt body may be configured to form a cylindrical portion with a decreasing diameter relative to the ends 1726, 1727 of the shunt body. One or more ends 1726, 1727 may be configured to extend beyond an opening 1714 of the tissue wall 1721 and / or extend out of an opening 1714 of the tissue wall 1721 and / or the cylindrical portion may be configured to be at least partially located within the opening 1714. In some examples, the shunt body may have at least a partially curved form and / or may have an hourglass shape, such that the diameter of the shunt body may gradually decrease between the first end 1726 and the cylindrical portion, and / or gradually increase from the cylindrical portion to the second end 1727.

[0141] The shunt body can have any suitable shape and / or the wire network forming the shunt body can have any suitable pattern. In some examples, the shunt body can be at least partially compressible and / or deployable to allow the shunt body to be in a compressed form while within the delivery device and / or deployable upon removal from the delivery device. The shunt body can be configured to be retractable after delivery. In some examples, the shunt body can be at least partially made of shape memory alloy and / or can be otherwise configured to... Figure 17 The shape shown is configured so that the main body of the distributor can be naturally presented after being removed from the delivery device. Figure 17 The shape shown.

[0142] In some examples, the shunt body can be configured to rotate and / or otherwise adjust after delivery to a desired position relative to the tissue wall 1721. For example, after at least a portion of the shunt body is placed within an opening through the tissue wall, the shunt body can be rotated laterally to adjust the position of the sensor base 1705 and / or adjust the position of one or more sensors coupled to the sensor base 1705. Thus, one or more sensors 1704 coupled to the shunt body can be rotated and oriented as needed. In some examples, the sensor base 1705 can be configured to position one or more sensors extending at least partially over and / or from the cylindrical portion of the shunt body to an offset position. The sensor base 1705 can have, for example, […]. Figure 17 The sensor base 1705 is generally circular in shape. However, the sensor base 1705 can have any suitable shape and / or can be configured to provide a platform for placing one or more sensors. In some examples, the sensor base 1705 can be configured to extend away from the cylindrical portion and / or be coupled to and / or extend into the sensor base 1705 with one or more wire extensions. The sensor base 1705 can be configured to extend away from the cylindrical portion to prevent obstruction of the cylindrical portion. In some examples, one or more coils 1713 can be used to attach one or more sensors 1704 to the sensor base 1705.

[0143] While the shunt body can be used independently of other implantable devices in some cases, it can be used additionally or alternatively in conjunction with one or more additional implantable devices. For example, the shunt body can be used in conjunction with a shunt implant 1702, which can be configured to form a fluid conduit through an opening 1714 in a tissue wall 1721. The shunt implant 1702 may include one or more anchoring arms configured to anchor to a first side 1722 and / or a second side (i.e., the superior wall 1723 of the coronary sinus 16) of the tissue wall 1721. In some examples, the implant 1702 may include a cylindrical portion 1712 configured to be placed within the opening 1714 and / or configured to form a fluid conduit through the opening 1714. The cylindrical portion of the shunt body can be configured to extend through at least a portion of the cylindrical portion 1712 of the shunt implant 1702. Sensor 1704 can be configured to be located at any position relative to opening 1714 and / or shunt implant 1702. For example, sensor 1704 can be configured to be located above at least a portion of the cylindrical portion 1712 of shunt implant 1702. However, sensor 1704 can additionally or alternatively be positioned away from opening 1714 of the cylindrical portion 1712 and / or tissue wall 1721 of shunt implant 1702.

[0144] Figure 18A and 18B The illustration shows a sensor implantation device 1800 according to one or more examples, including a sensor 1804 connected to a shunt body via one or more tethers 1805. The shunt body includes one or more self-deploying anchoring arms 1803. The one or more self-deploying anchoring arms 1803 may include attachment features 1809 (e.g., hook-shaped ends) configured to engage and / or mate with a tissue wall 1821 and / or one or more shunt implantation devices 1802. For example, the sensor implantation device 1800 may be configured to deploy in conjunction with a shunt implantation device 1802, such as... Figure 18B As shown. One or more anchoring arms 1803 may be configured to hook onto various struts / wires, units, and / or other features of the shunt implant device 1802. For example, one or more attachment features 1809 of the sensor implant device 1800 may include hooks configured to at least partially hook around one or more struts at the cylindrical portion 1812 and / or other portions of the shunt implant device 1802. Although the sensor implant device 1800 is shown as including three anchoring arms 1803, the sensor implant device 1800 may include any number of anchoring arms 1803.

[0145] The tether 1805 connecting one or more anchor arms 1803 to the sensor 1804 can have a rigid or flexible structure. In some examples, the tether 1805 can be configured to maintain a given angle 1831 relative to the axis 1832 of the one or more anchor arms 1803. For example, the axis 1832 can represent an imaginary line through the opening 1814 of the tissue wall 1821 and / or through the tubular portion 1812 of the shunt implant 1802. The tether 1805 can be configured to position the sensor 1804 outside and / or off-center from the opening 1814 of the tissue wall 1821 and / or the tubular portion 1812 of the shunt implant 1802.

[0146] The shunt implant 1802 may be configured to form a fluid conduit through an opening 1814 in the tissue wall 1821. The shunt implant 1802 may include one or more anchoring arms configured to anchor to a first side 1822 and / or a second side (i.e., the superior wall 1823 of the coronary sinus 16) of the tissue wall 1821. In some examples, the implant 1802 may include a cylindrical portion 1812 configured to be placed within the opening 1814 and / or configured to form a fluid conduit through the opening 1814. One or more anchoring arms 1803 of the sensor implantation device 1800 may be configured to pass through at least a portion of the cylindrical portion 1812 of the shunt implant 1802. The sensor 1804 may be configured to be located at any position relative to the opening 1814 and / or the shunt implant 1802. For example, the sensor 1804 may be configured to be located above at least a portion of the cylindrical portion 1812 of the shunt implant 1802. However, the sensor 1804 may additionally or alternatively be positioned off-center from the opening 1814 of the cylindrical portion 1812 of the shunt implant 1802 and / or the tissue wall 1821.

[0147] Figure 19A The illustration shows a sensor implantation device 1900 according to one or more examples, which includes a sensor 1904 connected to a shunt body 1903 via one or more tethers 1905. Figure 19B The illustration depicts a sensor implantation system including a sensor implantation device 1900 and / or a shunt implantation device 1902 implanted at an opening 1914 in a tissue wall 1921. The shunt body 1903 may have a generally tubular form and / or may have an hourglass shape. For example, the first implant may have a generally curved form, wherein the cylindrical portion 1907 (i.e., the middle section) of the shunt body 1903 has a smaller diameter than the shunt body 1903 at a first end 1926 and / or a second end 1927. In some examples, the sensor implantation device 1900 may be configured to unfold in conjunction with the shunt implantation device 1902, such as... Figure 19BAs shown. The first end 1926 and / or the second end 1927 may be configured to extend at least partially over at least a portion of the shunt implantation device 1902 and / or the tissue wall 1921. For example, the first end 1926 may be configured to extend over a first side 1922 of the tissue wall 1921 and / or the second end 1927 may be configured to extend over a second side 1923 of the tissue wall 1921.

[0148] The tether 1905 connecting the shunt body 1903 to the sensor 1904 can have a rigid or flexible structure. The shunt implant 1902 can be configured to form and / or maintain a fluid conduit through an opening 1914 in the tissue wall 1921. The shunt implant 1902 may include one or more anchoring arms configured to anchor to a first side 1922 and / or a second side (i.e., the superior wall 1923 of the coronary sinus 16) of the tissue wall 1921. In some examples, the implant 1902 may include a cylindrical portion 1912 configured to be placed within the opening 1914 and / or configured to form a fluid conduit through the opening 1914. The shunt body 1903 can be configured to pass through at least a portion of the cylindrical portion 1912 of the shunt implant 1902. The sensor 1904 can be configured to be located at any position relative to the opening 1914 and / or the shunt implant 1902. For example, sensor 1904 may be configured to be located on at least a portion of the cylindrical portion 1912 of shunt implant 1902. However, sensor 1904 may additionally or alternatively be positioned off-center from the opening 1914 of the cylindrical portion 1912 and / or tissue wall 1921 of shunt implant 1902.

[0149] Figure 20A The illustration shows a sensor implantation device 2000 according to one or more examples, which includes a sensor 2004 connected to a shunt body 2003 via one or more connecting arms 2005. Figure 20B The illustration depicts a sensor implantation system including a sensor implantation device 2000 and / or a shunt implant 2002 implanted at an opening 2014 in a tissue wall 2021. The shunt body 2003 may have a generally tubular form and / or may have an hourglass shape. In some examples, the sensor implantation device 2000 may be configured to deploy in conjunction with the shunt implantation device 2002, such as... Figure 20B As shown. In some examples, one or more connecting arms 2005 may include multiple wires and / or lines forming one or more rhomboid and / or triangular units. For example, connecting arm 2005 may include a wire network forming two rhomboid units and / or two triangular units.

[0150] One or more connecting arms 2005 that connect the shunt body 2003 to the sensor 2004 may have a rigid or flexible structure. The shunt implant 2002 may be configured to form and / or maintain a fluid conduit through an opening 2014 in the tissue wall 2021. The shunt implant 2002 may include one or more anchoring arms configured to anchor to a first side 2022 and / or a second side (i.e., the superior wall 2023 of the coronary sinus 16) of the tissue wall 2021. In some examples, the implant 2002 may include a cylindrical portion 2012 configured to be placed within the opening 2014 and / or configured to form a fluid conduit through the opening 2014. The shunt body 2003 may be configured to pass through at least a portion of the cylindrical portion 2012 of the shunt implant 2002. The sensor 2004 may be configured to be located at any position relative to the opening 2014 and / or the shunt implant 2002. For example, sensor 2004 may be configured to be located on at least a portion of the cylindrical portion 2012 of shunt implant 2002. However, sensor 2004 may additionally or alternatively be positioned off-center from the opening 2014 of the cylindrical portion 2012 and / or tissue wall 2021 of shunt implant 2002.

[0151] Figures 21A-21C Another sensor implantation device 2100 according to one or more examples is illustrated, which includes a sensor 2104 coupled to a shunt body 2103 of the sensor implantation device 2100. The shunt body 2103 may be C-shaped and / or may have a partially cylindrical form, wherein a gap 2128 separates a first end 2126 and a second end 2127 of the shunt body 2103. The shunt body 2103 may include one or more elongated orifices 2129 to allow blood to flow through the shunt body 2103.

[0152] In some examples, sensor 2104 can be coupled to the shunt body 2103 using sensor base 2105 and / or an arm extending from and / or coupled to the shunt body 2103. Sensor base 2105 may be configured to at least partially position sensor 2104 above the shunt body 2103 and / or above the opening 2114 through the tissue wall 2121 and / or may be configured to position sensor 2104 at an angle relative to the shunt body 2103 and / or at least partially offset from the opening 2114 through the tissue wall 2121.

[0153] The splitter body 2103 may include one or more tabs 2125 extending from the splitter body 2103. In some examples, the one or more tabs 2125 may be configured to attach to various delivery systems.

[0154] like Figure 21BAs shown, the shunt body 2103 may be at least partially compressible and / or deployable. For example, the shunt body 2103 may be configured to reduce its diameter by allowing the first end 2126 and the second end 2127 to at least partially overlap. In some examples, the sensor 2104 may be linearly oriented relative to the shunt body 2103 when within the delivery device 2106 (e.g., a conduit) and / or may be configured to be angled relative to the shunt body 2103 after being removed from the delivery device 2106.

[0155] In some examples, the sensor implantation device 2100 can be configured to be deployed in conjunction with the shunt implantation device 2102, such as Figure 21C As shown. The shunt implant 2102 may be configured to form and / or maintain a fluid conduit through an opening 2114 in the tissue wall 2121. The shunt implant 2102 may include one or more anchoring arms configured to anchor to a first side 2122 and / or a second side (i.e., the superior wall 2123 of the coronary sinus 16) of the tissue wall 2121. In some examples, the implant 2102 may include a cylindrical portion 2112 configured to be placed within the opening 2114 and / or configured to form a fluid conduit through the opening 2114. A shunt body 2103 may be configured to pass through at least a portion of the cylindrical portion 2112 of the shunt implant 2102. A sensor 2104 may be configured to be located at any position relative to the opening 2114 and / or the shunt implant 2102. For example, the sensor 2104 may be configured to be located above at least a portion of the cylindrical portion 2112 of the shunt implant 2102. However, the sensor 2104 may additionally or alternatively be positioned off-center from the opening 2114 of the cylindrical portion 2112 and / or tissue wall 2121 of the shunt implant 2102.

[0156] Figure 22 A flowchart illustrating the steps of process 2200 for delivering one or more sensor implantation devices and / or shunt devices described herein, according to one or more examples, is provided. Although process 2200 is shown in a step-by-step sequence, some steps of process 2200 may be performed simultaneously and / or in a different order.

[0157] At step 2202, process 2200 involves percutaneously and / or via a catheter and / or other delivery system delivering a shunt implant into an opening in the tissue wall. The shunt implant may include, for example... Figure 7The shunt / anchoring structure 150 shown is illustrated. For example, the shunt implant may include a cylindrical portion configured to be at least partially placed within an opening and / or the shunt implant may include one or more anchoring arms configured to anchor to a tissue wall. The shunt implant may be configured to form and / or maintain a fluid conduit through an opening in the tissue wall. The opening may be created during a puncture procedure performed prior to delivery of the shunt implant.

[0158] At step 2204, process 2200 involves percutaneously and / or via a catheter and / or other delivery system delivering a sensor implantation device to an opening in the tissue wall. In some examples, the sensor implantation device may be delivered together with a shunt implant and / or via the same catheter used to deliver the shunt implant. However, the shunt implant and the sensor implantation device may be delivered separately and / or during separate medical procedures. In some examples, the shunt implant may be delivered prior to the sensor implantation device. For example, the shunt implant may be anchored at the opening and the sensor implantation device may be subsequently delivered and / or may at least partially pass through the cylindrical portion of the shunt implant. The sensor implantation device may include various features, including anchoring arms, hooks, deployable shunt bodies, and / or curved ends, configured to anchor to the shunt implant and / or the tissue wall. Alternatively, the sensor implantation device may be delivered prior to the delivery of the shunt implant. For example, a sensor implantation device may include various features, such as anchoring arms, hooks, deployable cylindrical portions, and / or curved ends, configured to independently anchor the sensor implantation device to a tissue wall and / or at least partially anchor it within an opening. A shunt implant may then be delivered and / or may at least partially pass through the shunt body of the sensor implantation device.

[0159] At step 2206, process 2200 involves extending at least a portion of the sensor implantation device at least partially through the cylindrical portion of the shunt device. For example, the shunt implant may include a generally tubular cylindrical portion forming an inner cavity through the shunt implant. In some examples, the sensor implantation device may include a generally tubular shunt body with a diameter smaller than the cylindrical portion of the shunt implant, such that the shunt body of the sensor implantation device can be configured to at least partially fit within the cylindrical portion of the shunt implant.

[0160] Alternatively, the shunt implant may extend at least partially through the shunt body of the sensor implantation device. For example, the cylindrical portion of the shunt implant may be smaller in diameter than the cylindrical portion of the sensor implantation device, such that the cylindrical portion of the shunt implant may be configured to at least partially fit within the shunt body of the sensor implantation device.

[0161] At step 2208, process 2200 involves rotating the sensor implantation device as needed to adjust the position of the sensor coupled to the sensor implantation device until the desired position of the sensor is achieved. The sensor may extend above, diagonally away from, and / or perpendicular to the shunt body of the sensor implantation device. As the sensor implantation device is rotated, the sensor may be moved to be positioned above and / or near different portions of the tissue wall and / or within different portions of the heart chamber.

[0162] At step 2210, process 2200 involves removing the catheter and / or other delivery system from the body. The shunt and / or sensor implantation device may remain in the body.

[0163] Some embodiments of this disclosure relate to a sensor implantation system including a shunt implant with a central flow portion configured to maintain an opening through a tissue wall, and a sensor implantation device including a shunt body configured to be at least partially fitted within the central flow portion and a sensor coupled to the shunt body.

[0164] The sensor can be configured to extend at least partially above an opening through the tissue wall. In some examples, the sensor is configured to extend at least partially above the tissue wall.

[0165] In some examples, the sensor is coupled to the shunt body via an arm extending from the shunt body. The arm may form one or more coils around the sensor.

[0166] The splitter body may further include one or more anchoring arms. In some examples, the splitter body has a cylindrical shape.

[0167] In some examples, the shunt body includes a wire loop having a proximal portion configured to present a first width within the central flow portion of the shunt implant and a distal portion configured to extend beyond a second width beyond the central flow portion of the shunt implant. The second width may be greater than the first width.

[0168] The loop can be configured to extend to a second width beyond a first side of the tissue wall. In some examples, the sensor is configured to extend beyond a second side of the tissue wall.

[0169] In some examples, the wire loop is at least partially made of one or more shape memory alloys. The proximal portion of the wire loop is configured to be at least partially located within the central flow portion of the shunt implant.

[0170] A wire loop may include a first end and a second end connected to the sensor. In some examples, the wire loop is configured to form one or more coils around the sensor.

[0171] In some examples, the shunt body includes a coil having a proximal portion configured to form a first width within the central flow portion of the shunt implant and a distal portion configured to form a second width exceeding the central flow portion of the shunt implant. The second width may be greater than the first width.

[0172] The shunt body can be configured to form a second width extending beyond the first side of the tissue wall. In some examples, the sensor is configured to extend beyond the second side of the tissue wall.

[0173] In some examples, the coil includes a first end configured to form one or more windings around the sensor. The coil may include a second end at the distal portion.

[0174] The coil can have multiple windings in both the proximal and distal portions. In some examples, the coil is configured to hold the sensor above the proximal portion of the coil.

[0175] In some examples, the coil is configured to keep the sensor at least partially offset from the proximal portion of the coil.

[0176] The splitter body may have an hourglass shape, wherein the middle section of the splitter body has a first diameter, and the splitter body extends to a second diameter at both the first and second ends of the splitter body. In some examples, the second diameter is larger than the first diameter.

[0177] In some examples, the shunt body includes a sensor base located at a first end. The sensor can be configured to be coupled to the shunt body at the sensor base.

[0178] The main body of the shunt may include a network of struts forming units. In some examples, at least a portion of the unit is rhomboid in shape.

[0179] In some examples, the diverter body includes one or more protrusions at a second end, which are configured to mate with one or more delivery devices. The diverter body may have a partially cylindrical form with a gap separating the first end of the diverter body from the second end of the diverter body.

[0180] The splitter body can be configured to take on a compressed form during delivery, wherein the first end at least partially overlaps with the second end.

[0181] In some examples, the shunt body includes multiple anchor arms configured to engage with the shunt implant. Each anchor arm can be connected to a tether that interconnects the sensor and the anchor arm.

[0182] The tether can be configured to extend the sensor at least partially above the tissue wall. In some examples, the sensor implantation system further includes a connecting arm that interconnects the sensor and the shunt body. The connecting arm may include a network of struts forming a rhomboid unit.

[0183] Some embodiments of this disclosure relate to a method including delivering a shunt implant into an opening in a tissue wall. The shunt implant includes a central flow portion configured to maintain the opening. The method further includes delivering a sensor implantation device into the opening in the tissue wall. The sensor implantation device includes a shunt body configured to be at least partially fitted within the central flow portion of the shunt implant and a sensor coupled to the shunt body. The method further includes rotating the sensor implantation device to adjust the position of the sensor.

[0184] In some examples, the shunt body includes a coil configured to form a first width within the central flow portion of the shunt implant and a second width exceeding the central flow portion of the shunt implant. The second width may be greater than the first width.

[0185] The shunt body can be configured to form a second width extending beyond the first side of the tissue wall. In some examples, the sensor is configured to extend beyond the second side of the tissue wall.

[0186] According to some embodiments of this disclosure, a sensor implantation device includes a shunt body configured to be at least partially assembled within a central flow portion of a shunt implant and a sensor coupled to the shunt body.

[0187] The splitter body may have an hourglass shape, wherein the middle section of the splitter body has a first diameter, and the splitter body extends to a second diameter at both the first and second ends of the splitter body. In some examples, the second diameter is larger than the first diameter.

[0188] In some examples, the shunt body includes a sensor base located at a first end. The sensor can be configured to be coupled to the shunt body at the sensor base.

[0189] The main body of the shunt may include a network of struts forming units. In some examples, at least a portion of the unit is rhomboid in shape.

[0190] In some examples, the shunt body includes one or more protrusions at a second end, which are configured to mate with one or more delivery devices. The sensor may be configured to extend at least partially above an opening through the tissue wall.

[0191] The sensor can be configured to extend at least partially above the tissue wall. In some examples, the sensor is coupled to the shunt body via an arm extending from the shunt body.

[0192] In some examples, the arm forms one or more coils around the sensor. The shunt body can have a cylindrical shape.

[0193] The shunt body may include a wire loop having a proximal portion configured to present a first width within an opening in the tissue wall and a distal portion configured to extend beyond the opening in the tissue wall to a second width. In some examples, the second width is greater than the first width.

[0194] In some examples, the loop is configured to extend to a second width beyond the first side of the tissue wall. The sensor can be configured to extend beyond the second side of the tissue wall.

[0195] The wire loop may be at least partially made of one or more shape memory alloys. In some examples, the wire loop includes a first end and a second end connected to the sensor.

[0196] In some examples, the wire loop is constructed to form one or more coils around the sensor.

[0197] The shunt body may include a coil having a proximal portion configured to form a first width within an opening in the tissue wall and a distal portion configured to form a second width extending beyond the tissue wall. In some examples, the second width is greater than the first width.

[0198] In some examples, the shunt body is configured to form a second width extending beyond the first side of the tissue wall. The sensor can be configured to extend beyond the second side of the tissue wall.

[0199] The coil may include a first end configured to form one or more windings around the sensor. In some examples, the coil includes a second end at a distal portion.

[0200] In some examples, the coil has multiple windings at both the proximal and distal portions. The coil can be configured to hold the sensor above the proximal portion of the coil.

[0201] The coil can be configured to keep the sensor at least partially offset from the proximal portion of the coil. In some examples, the shunt body has a partially cylindrical form with a gap separating a first end of the shunt body from a second end of the shunt body.

[0202] In some examples, the splitter body is configured to take on a compressed form during delivery, wherein the first end at least partially overlaps with the second end.

[0203] The sensor implantation device may further include a connecting arm that interconnects the sensor and the shunt body. In some examples, the connecting arm includes a network of struts forming a rhomboid unit.

[0204] Other examples

[0205] Depending on the examples, certain actions, events, or functions of any process or algorithm described herein may be performed in a different order, or may be added, combined, or omitted entirely. Therefore, in some examples, not all described actions or events are necessary for the practice of the process.

[0206] Unless otherwise expressly stated, or otherwise understood in the context in which they are used, the conditional language used herein, such as “may,” “can,” “possibly,” or “may,” “for example,” etc., is intended in its ordinary sense and generally intended to express that some examples include certain features, elements, and / or steps, while other examples do not include said features, elements, and / or steps. Therefore, such conditional language is not generally intended to imply that one or more examples require the feature, element, and / or step in any way, or that one or more examples must include logic for determining whether to include these features, elements, and / or steps or to perform these features, elements, and / or steps in any particular example, whether or not the author has entered or prompted it. The terms “comprise,” “include,” “have,” etc., are synonyms, used in their ordinary sense, and used inclusively in an open-ended manner, without excluding additional elements, features, behaviors, operations, etc. Furthermore, the term “or” is used in its inclusive sense (rather than in its exclusive sense) so that, for example, when used to connect lists of elements, the term “or” indicates one, some, or all of the elements in the list. Unless otherwise specified, conjunctions such as “at least one of X, Y, and Z” are understood to be used in context to convey items, terms, elements, etc., which can be any one of X, Y, or Z. Therefore, such conjunctions are generally not intended to imply that some example requires the presence of at least one of X, at least one of Y, and at least one of Z.

[0207] It should be understood that in the above description of the various examples, various features are sometimes combined together in a single example, figure, or description therein in order to simplify this disclosure and aid in understanding one or more aspects of the invention. However, this approach of the disclosure should not be construed as reflecting an intention that any claim requires more features than those expressly recited in that claim. Furthermore, any component, feature, or step illustrated and / or described in the specific embodiments herein may be applied to or used with any other one or more examples. Moreover, for each example, no component, feature, step, or group of components, features, or steps is necessary or indispensable. Therefore, the scope of the invention disclosed herein and claimed below should not be limited to the specific examples described above, but should be determined solely by a reasonable reading of the appended claims.

[0208] It should be understood that certain ordinal numbers (e.g., "first" or "second") may be provided for ease of reference and do not necessarily imply physical characteristics or order. Therefore, as used herein, ordinal numbers used to modify elements such as structures, components, operations, etc. (e.g., "first," "second," "third," etc.) do not necessarily indicate the element's priority or order relative to any other element, but generally distinguish the element from another element with a similar or identical name (but are used in ordinal numbers). Furthermore, as used herein, indefinite articles ("a" and "one") can mean "one or more" rather than "one." Additionally, operations performed "based on" conditions or events can also be performed based on one or more other conditions or events not explicitly listed.

[0209] Unless otherwise defined, all terms used herein, including technical and scientific terms, have the same meaning as commonly understood by one of ordinary skill in the art to which the examples pertain. It should be further understood that terms defined in commonly used dictionaries should be interpreted as having a meaning consistent with their meaning in the context of the relevant field and should not be interpreted as having an idealized or overly formal meaning unless expressly defined herein.

[0210] The spatial relative terms “external,” “internal,” “upper,” “lower,” “below,” “above,” “vertical,” “horizontal,” and similar terms are used herein for the convenience of describing the relationship between one element or component and another element or component as shown in the figures. It should be understood that, in addition to the orientations depicted in the figures, the spatial relative terms are intended to include different orientations of the device in use or operation. For example, in the case where the device shown in the figures is flipped, a device located “below” or “below” another device may be placed “above” another device. Therefore, the descriptive term “below” can include both lower and upper positions. The device may also be oriented in another direction, and thus the spatial relative terms can be interpreted differently depending on the orientation.

[0211] Unless otherwise expressly stated, terms for comparison and / or quantity, such as “less,” “more,” “greater,” etc., are intended to encompass the concept of equivalence. For example, “less” can mean not only “less” in the strictest mathematical sense, but also “less than or equal to.”

Claims

1. A sensor implantation system, comprising: Shunt implants include a central flow portion configured to maintain an opening through the tissue wall; as well as A sensor implantation device includes a shunt body configured to be at least partially fitted within the central flow portion of the shunt implant and a sensor coupled to the shunt body. The shunt body includes a wire loop having a proximal portion configured to present a first width within the central flow portion of the shunt implant and a distal portion configured to extend beyond the central flow portion of the shunt implant to a second width, wherein the second width is greater than the first width. The wire loop is configured to be attached to a first end of the sensor at a first point and to a second end of the sensor at a second point. and The distal portion of the shunt body is configured to prevent the shunt body from escaping upward through the opening in the tissue wall.

2. The sensor implantation system according to claim 1, wherein, The sensor is configured to extend at least partially over the opening that passes through the tissue wall.

3. The sensor implantation system according to claim 1 or claim 2, wherein, The sensor is configured to extend at least partially above the tissue wall.

4. The sensor implantation system according to any one of claims 1 to 2, wherein, The sensor is connected to the splitter body via an arm extending from the splitter body.

5. The sensor implantation system according to claim 4, wherein, The arm forms one or more coils around the sensor.

6. The sensor implantation system according to any one of claims 1 to 2, wherein, The shunt implant further includes one or more anchoring arms configured to anchor to a first or second side of the tissue wall.

7. The sensor implantation system according to claim 1, wherein, The loop is configured to extend beyond a first side of the tissue wall to the second width, and the sensor is configured to extend beyond a second side of the tissue wall.

8. The sensor implantation system according to claim 1 or claim 7, wherein, The loop is at least partially made of one or more shape memory alloys.

9. The sensor implantation system according to any one of claims 1 to 2, wherein, The proximal portion of the loop is configured to be at least partially located within the central flow portion of the shunt implant.

10. A delivery system for a splitter, comprising: The delivery device is configured as follows: A shunt implant is delivered into an opening in a tissue wall, the shunt implant including a central flow portion configured to maintain the opening; Delivering a sensor implantation device into the opening in the tissue wall, the sensor implantation device comprising a shunt body configured to be at least partially fitted within the central flow portion of the shunt implant and a sensor coupled to the shunt body; as well as Rotate the sensor implantation device to adjust the position of the sensor. The shunt body includes a wire loop configured to form a first width within the central flow portion of the shunt implant and a second width extending beyond the central flow portion of the shunt implant, wherein the second width is greater than the first width. The wire loop has a configuration to attach to a first end of the sensor at a first point and a configuration to attach to a second end of the sensor at a second point; and The distal portion of the shunt body is configured to prevent the shunt body from escaping upward through the opening in the tissue wall.

11. The delivery system according to claim 10, wherein, The shunt body is configured to form the second width beyond a first side of the tissue wall, and the sensor is configured to extend beyond a second side of the tissue wall.

12. A sensor implantation device, comprising: The shunt body is configured to be at least partially fitted within the central flow portion of the shunt implant; as well as The sensor connected to the main body of the shunt, The shunt body includes a wire loop having a proximal portion configured to present a first width within the central flow portion of the shunt implant and a distal portion configured to extend beyond the central flow portion of the shunt implant to a second width, wherein the second width is greater than the first width. The wire loop is configured to be attached to a first end of the sensor at a first point and to a second end of the sensor at a second point. and The distal portion of the shunt body is configured to prevent the shunt body from escaping upward through an opening in the tissue wall.

13. The sensor implantation device according to claim 12, wherein, The sensor is configured to extend at least partially over the opening that passes through the tissue wall.

14. The sensor implantation device according to claim 13, wherein, The sensor is configured to extend at least partially above the tissue wall.

15. The sensor implantation device according to claim 12, wherein, The sensor is connected to the splitter body via an arm extending from the splitter body.

16. The sensor implantation device according to claim 15, wherein, The arm forms one or more coils around the sensor.

17. The sensor implantation device according to claim 13, wherein, The loop is configured to extend beyond a first side of the tissue wall to the second width, and the sensor is configured to extend beyond a second side of the tissue wall.

18. The sensor implantation device according to claim 12 or claim 17, wherein, The loop is at least partially made of one or more shape memory alloys.

Citation Information

Patent Citations

  • Expandable cardiac shunt

    US9789294B2

  • Shunt cartridge sensor implant anchoring

    CN217723818U

  • Cardiac implant devices with integrated pressure sensing

    WO2020123338A1